IN FORCE undated

172 National List of Essential Medicines 2022 2022-Sep-13 4579 KB

Document text

National List of Essential Medicines 2022

Table of Contents

Sections of Drug Classes Section 1 Medicines used in Anaesthesia ............................................................................ 3 Section 2 Analgesics, Antipyretics, Non-steroidal Anti-inflammatory
Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders ............................................................................. 6 Section 3 Antiallergics and Medicines used in Anaphylaxis ............................................... 9 Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation ................................................................................. 11 Section 5 Medicines used in Neurological Disorders ....................................................... 13 Section 6 Anti-infective Medicines .................................................................................... 18 Section 7 Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care .................................................................................................... 37 Section 8 Medicines affecting Blood ................................................................................. 45 Section 9 Blood products and Plasma substitutes .............................................................. 47 Section 10 Cardiovascular Medicines ................................................................................

asma substitutes .............................................................. 47 Section 10 Cardiovascular Medicines ................................................................................ 49 Section 11 Dermatological Medicines (Topical) ............................................................... 54 Section 12 Diagnostic agents ............................................................................................. 56 Section 13 Dialysis components (Haemodialysis and Peritoneal Dialysis) ...................... 57 Section 14 Antiseptics and Disinfectants ........................................................................... 57 Section 15 Diuretics ........................................................................................................... 58 Section 16 Ear, Nose and Throat Medicines ...................................................................... 59 Section 17 Gastrointestinal Medicines ............................................................................... 60 Section 18 Hormones, other Endocrine Medicines and Contraceptives ............................ 63

estinal Medicines ............................................................................... 60 Section 18 Hormones, other Endocrine Medicines and Contraceptives ............................ 63

Section 19 Immunologicals ................................................................................................ 67 Section 20 Medicines for Neonatal Care ........................................................................... 70 Section 21 Ophthalmological Medicines ........................................................................... 71 Section 22 Oxytocics and Antioxytocics ........................................................................... 73 Section 23 Medicines used in treatment of Psychiatric Disorders..................................... 74 Section 24 Medicines acting on the Respiratory tract ....................................................... 78 Section 25 Solutions correcting Water, Electrolyte disturbances and Acid-base disturbances...................................................................................................... 80 Section 26 Vitamins and Minerals ..................................................................................... 81 Section 27 Medicines for COVID 19 management ......................................................... 82 Alphabetical List of Medicines in NLEM 2022 ............................................................... 84 Medicines Added Therapeutic category wise in NLEM 2022 .......................................

ical List of Medicines in NLEM 2022 ............................................................... 84 Medicines Added Therapeutic category wise in NLEM 2022 ....................................... 101 Alphabetical List of Medicines Added to NLEM 2022 ................................................... 113 Medicines Deleted from Therapeutic category wise NLEM 2015 ................................ 116 Alphabetical List of Medicines Deleted from NLEM 2015 ............................................ 127 INDEX 130

Section 1 Medicines used in Anaesthesia 1.1- General Anaesthetics and Oxygen

Medicine Level of Healthcare Dosage form(s) and strength(s) 1.1.1 Halothane S,T Liquid for inhalation 1.1.2 Isoflurane S,T Liquid for inhalation 1.1.3 Ketamine P,S,T Injection 10 mg/mL Injection 50 mg/mL 1.1.4 Nitrous oxide P,S,T As licensed for medical purpose 1.1.5 Oxygen* P,S,T As licensed for medical purpose 1.1.6 Propofol P,S,T Injection 10 mg/mL 1.1.7 Sevoflurane S,T Liquid for inhalation 1.1.8 Thiopentone P,S,T Powder for injection 0.5 g Powder for injection 1 g *Oxygen is also listed in Section 27.5 - Medicines for COVID 19 management

Sevoflurane S,T Liquid for inhalation 1.1.8 Thiopentone P,S,T Powder for injection 0.5 g Powder for injection 1 g *Oxygen is also listed in Section 27.5 - Medicines for COVID 19 management

1.2-Local Anaesthetics

Medicine Level of 1.2.1 Bupivacaine S,T Injection 0.25 % Injection 0.5 % Injection 0.5 % with 7.5 % glucose 1.2.2 Lignocaine* P,S,T Topical forms 2-5 % Injection 1 % Injection 2 %
Injection 5 % with 7.5 % glucose 1.2.3 Lignocaine (A) + Adrenaline (B) P,S,T Injection 1% (A) + 1:200000
(5 mcg/mL) (B) Injection 2% (A) + 1:200000
(5 mcg/mL) (B) 1.3- Preoperative Medication and Sedation for Short Term Procedures

Medicine Level of 1.3.1 Atropine** P,S,T Injection 0.6 mg/mL *Lignocaine formulations are also listed in Section 10.2.5 cardiovascular medicines- Antiarrhythmic medicines
**Atropine formulations are also listed in -
A. Section 4.2.1 - Antidotes and Other Substances used in Management of Poisonings/Envenomation - Specific B. Section 21.5.1 - Ophthalmological Medicines- Mydriatics

ations are also listed in -
A. Section 4.2.1 - Antidotes and Other Substances used in Management of Poisonings/Envenomation - Specific B. Section 21.5.1 - Ophthalmological Medicines- Mydriatics

Medicine Level of 1.3.2 Glycopyrrolate S,T Injection 0.2 mg/mL 1.3.3 Midazolam* P,S,T Tablet 7.5 mg Nasal Spray 0.5mg Nasal Spray 1.25 mg Injection 1 mg/mL Injection 5 mg/mL 1.3.4 Morphine** P,S,T Injection 10 mg/mL Injection 15 mg/mL Section 1.4 -Muscle Relaxants and Cholinesterase Inhibitors

Medicine Level of 1.4.1 Atracurium S,T Injection 10 mg/mL 1.4.2 Baclofen S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg *Midazolam formulations are also listed in - A. Section 5.1.7- Medicines used in Neurological Disorders Anticonvulsants/ Antiepileptics
B. Section 7.4.12- Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

**Morphine formulations are also listed in - A. Section 2.2.2- Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Opioid Analgesics B. Section 7.4.13 - Anti-cancer agents including immunosuppressives, and medicines used in Palliative Care

treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Opioid Analgesics B. Section 7.4.13 - Anti-cancer agents including immunosuppressives, and medicines used in Palliative Care

Medicine Level of 1.4.3 Neostigmine* S,T Tablet 15 mg Injection 0.5 mg/mL 1.4.4 Succinylcholine S,T Injection 50 mg/mL 1.4.5 Vecuronium S,T Powder for injection 4 mg Powder for injection 10 mg Section 2 Analgesics, Antipyretics, Non-steroidal Anti-inflammatory
Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders

2.1 - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs

Medicine Level of 2.1.1 Acetylsalicylic acid** P,S,T

Tablet 300 mg to 500 mg Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500 mg

*Neostigmine formulations are also listed in Section 4.2.8 - Antidotes and Other substances used in Management of poisoning/Envenomation - Specific
**Acetylsalicylic acid formulations are also listed in - A. Section 5.2.1 - Medicines used in Neurological Disorders Antimigraine medicines
B. Section 10.5.1 - Cardiovascular medicines -Antithrombotic Medicines (Cardiovascular/ Cerebrovascular) - Antiplatelet and Antithrombotic Medicines

Neurological Disorders Antimigraine medicines
B. Section 10.5.1 - Cardiovascular medicines -Antithrombotic Medicines (Cardiovascular/ Cerebrovascular) - Antiplatelet and Antithrombotic Medicines

Medicine Level of 2.1.2 Diclofenac P,S,T Tablet 50 mg Injection 25 mg/mL 2.1.3 Ibuprofen* P,S,T Tablet 200 mg Tablet 400 mg Oral liquid 100 mg/5 mL (p) 2.1.4 Mefenamic acid P,S,T Tablet 250 mg Oral liquid 100 mg/5 mL (p) 2.1.5 Paracetamol** P,S,T Tablet 500 mg Tablet 650 mg Oral liquid 120 mg/5 mL (p) Oral Liquid 125 mg/5 mL (p) Oral Liquid 250 mg/5 mL (p) Injection 150 mg/ mL Suppository 80 mg Suppository 170 mg 2.2-Opioid Analgesics

Medicine Level of Healthcare Dosage form(s) and strength(s) 2.2.1 Fentanyl S,T Injection 50 mcg/mL *Ibuprofen formulations are also listed in Section 5.2.2 - Medicines used in Neurological Disorders-Antimigraine Medicines
** Paracetamol formulations are also listed in -
A. Section 5.2.3 - Medicines used in Neurological Disorders-Antimigraine Medicines
B. Section 27.4 - Medicines for COVID 19 Management

dicines
** Paracetamol formulations are also listed in -
A. Section 5.2.3 - Medicines used in Neurological Disorders-Antimigraine Medicines
B. Section 27.4 - Medicines for COVID 19 Management

Medicine Level of Healthcare 2.2.2 Morphine* P,S,T Tablet 10 mg Injection 10 mg/mL Injection 15 mg/mL 2.2.3 Tramadol** S,T Capsule 50 mg Capsule 100 mg Injection 50 mg/mL 2.3-Medicines used to treat Gout

Medicine Level of Healthcare 2.3.1 Allopurinol*** P,S,T Tablet 100 mg Tablet 300 mg 2.3.2 Colchicine P,S,T Tablet 0.5 mg *Morphine formulations are also listed in - A. Section 1.3.4 - Medicines used in Anaesthesia - Preoperative medication and sedation for short term procedures
B. Section 7.4.13 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care
** Tramadol formulations are also listed in
Section 7.4.15 - Tramadol formulations are also listed in Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

*** Allopurinol formulations are also listed in
Section 7.4.1 - Allopurinol formulations are also listed in Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

2.4-Disease Modifying Agents used in Rheumatoid Disorders

Medicine Level of Healthcare 2.4.1 Azathioprine* S,T Tablet 25 mg (p) Tablet 50 mg 2.4.2 Hydroxychloroquine P,S,T Tablet 200 mg Tablet 400 mg 2.4.3 Methotrexate** P,S,T Tablet 2.5 mg Tablet 5 mg Tablet 10 mg
2.4.4 Sulfasalazine S,T

Tablet 500 mg Section 3 Antiallergics and Medicines used in Anaphylaxis

Medicine Level of Healthcare 3.1 Adrenaline P,S,T Injection 1 mg/mL 3.2 Cetirizine P,S,T Tablet 10 mg Oral liquid 5 mg/5 mL (p)

Azathioprine formulations are also listed in Section 7.3.1 - Anti-cancer agents including
Immunosuppressives, and Medicines used in Palliative Care ** Methotrexate formulations are also listed in Section 7.1.30 - Anti-cancer agents including
Immunosuppressives, and Medicines used in Palliative Care

ves, and Medicines used in Palliative Care ** Methotrexate formulations are also listed in Section 7.1.30 - Anti-cancer agents including
Immunosuppressives, and Medicines used in Palliative Care

Medicine Level of Healthcare 3.3 Dexamethasone* P,S,T Tablet 0.5 mg Tablet 2 mg Tablet 4 mg Oral liquid 0.5 mg/5 mL (p) Injection 4 mg/mL 3.4 Hydrocortisone** P,S,T Tablet 5 mg Tablet 10 mg Powder for Injection 100 mg Powder for Injection 200 mg 3.5 Pheniramine P,S,T Injection 22.75 mg/mL 3.6 Prednisolone*** P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p) *Dexamethasone formulations are also listed in - A. Section 7.4.3 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care
B. Section 18.1.1 - Hormones, other Endocrine Medicines and Contraceptives - Adrenal Hormones and Synthetic Substitutes
C. Section 27.1 - Medicines for COVID 19 Management
** Hydrocortisone formulations are also listed in Section 18.1.3 - Hormones, other Endocrine Medicines and Contraceptives- Adrenal Hormones and Synthetic Substitutes
***Prednisolone formulations are also listed in - A. Section 7.2.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Hormones and Anti-Hormones used in cancer therapy
B. Section 18.1.5 - Hormones, other Endocrine Medicines and Contraceptives -Adrenal Hormones and Synthetic Substitutes
C. Section 21.2.1 - Ophthalmological Medicines- Anti-inflammatory Medicine

B. Section 18.1.5 - Hormones, other Endocrine Medicines and Contraceptives -Adrenal Hormones and Synthetic Substitutes
C. Section 21.2.1 - Ophthalmological Medicines- Anti-inflammatory Medicine

Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation
4.1-Nonspecific

Medicine Level of Healthcare 4.1.1 Activated Charcoal P,S,T Powder (as licensed) 4.2 Specific

Medicine Level of Healthcare 4.2.1 Atropine* P,S,T Injection 0.6 mg/mL
4.2.2 Calcium gluconate** P,S,T Injection 100 mg/mL 4.2.3 D- Penicillamine P,S,T Capsule 150 mg (p) Capsule 250 mg 4.2.4 Desferrioxamine S,T Powder for injection 500 mg 4.2.5 Methylthioninium chloride
(Methylene blue) S,T Injection 10 mg/mL *Atropine formulations are also listed in - A. Section 1.3.1 - Medicines used in Anaesthesia -Preoperative Medication and Sedation for short term procedures
B. Section 21.5.1 - Ophthalmological Medicines- Mydriatics ** Calcium gluconate formulations are also listed in Section 26.3 - Vitamins and minerals

ation and Sedation for short term procedures
B. Section 21.5.1 - Ophthalmological Medicines- Mydriatics ** Calcium gluconate formulations are also listed in Section 26.3 - Vitamins and minerals

Medicine Level of Healthcare 4.2.6 N-acetylcysteine P,S,T Sachet 200 mg Injection 200 mg/mL 4.2.7 Naloxone P,S,T Injection 0.4 mg/mL 4.2.8 Neostigmine* P,S,T Injection 0.5 mg/mL 4.2.9 Pralidoxime chloride (2-PAM) P,S,T Injection 25 mg/mL 4.2.10 Snake venom antiserum** P,S,T Soluble/ liquid polyvalent -
As licensed Lyophilized polyvalent -
As licensed 4.2.11 Sodium nitrite S,T Injection 30 mg/mL 4.2.12 Sodium thiosulphate S,T Injection 250 mg/mL

Neostigmine formulations are also listed in Section 1.4.3 - Medicines used in Anaesthesia -
Muscle relaxants and cholinesterase inhibitors
** Snake Venom antiserum is also listed in Section 19.2.7. - Immunologicals -
Sera and immunoglobulins (Liquid/ Lyophilized)

sed in Anaesthesia -
Muscle relaxants and cholinesterase inhibitors
** Snake Venom antiserum is also listed in Section 19.2.7. - Immunologicals -
Sera and immunoglobulins (Liquid/ Lyophilized)

Section 5
Medicines used in Neurological Disorders Section 5.1-Anticonvulsants/ Antiepileptics

Medicine Level of 5.1.1 Carbamazepine* P,S,T Tablet 100 mg Tablet 200 mg Tablet 400 mg Modified Release - Tablet 200 mg Tablet 400 mg Oral liquid 100 mg/5 mL (p) 5.1.2 Clobazam S,T Tablet 5 mg Tablet 10 mg 5.1.3 Diazepam** P,S,T Oral liquid 2 mg/5 mL (p) Injection 5 mg/mL Suppository 5 mg 5.1.4 Levetiracetam S,T Tablet 250 mg Tablet 500 mg Tablet 750 mg Modified Release Tablet 750 mg Oral liquid 100 mg/mL (p) Injection 100 mg/mL 5.1.5 Lorazepam P,S,T Tablet 1 mg Tablet 2 mg Injection 2 mg/mL Injection 4 mg/mL *Carbamazepine formulations are also listed in Section 23.2.2.3 Medicines used in treatment of Psychiatric disorder - Medicines used in Bipolar disorders ** Diazepam formulations are also listed in Section 7.4.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care

ar disorders ** Diazepam formulations are also listed in Section 7.4.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care

Medicine Level of 5.1.6 Magnesium sulphate S,T Injection 500 mg/mL 5.1.7 Midazolam* P,S,T Tablet 7.5 mg Tablet 15 mg Nasal Spray 0.5 mg/actuation Nasal Spray 1.25 mg/actuation Injection 1 mg/mL Injection 5 mg/mL

5.1.8

Phenobarbitone P,S,T Tablet 30 mg Tablet 60 mg Oral liquid 20 mg/5 mL (p) S,T Injection 200 mg/mL 5.1.9 Phenytoin P,S,T Tablet 50 mg Tablet 100 mg Tablet 300 mg
Modified Release Tablet 300 mg Oral liquid 30 mg/5 mL (p) Oral liquid 125 mg/5 mL (p) Injection 25 mg/mL Injection 50 mg/mL *Midazolam formulations are also listed in - A. Section 1.3.3 - Medicines used in Anaesthesia - Preoperative Medication and Sedation for short term procedures
B. Section 7.4.12 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care

e Medication and Sedation for short term procedures
B. Section 7.4.12 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care

Medicine Level of 5.1.10 Sodium Valproate* P,S,T Tablet 200 mg Tablet 300 mg
Tablet 500 mg Modified Release - Tablet 300 mg Tablet 500 mg Oral liquid 200 mg/5 mL (p) S,T Injection 100 mg/mL Section 5.2- Antimigraine Medicines

Medicine Level of 5.2.1 Acetylsalicylic acid** P,S,T Tablet 300 mg to 500 mg Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500 mg

*Sodium Valproate formulations are also listed in-
Section 23.2.2.2 - Medicines used in treatment of Psychiatric Disorders -Medicines used in Bipolar disorders- Medicines used in mood disorders
**Acetylsalicyclic acid formulations are also listed in - A. Section 2.1.1 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory
Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs B. Section 10.5.1 - Cardiovascular medicines- Antiplatelet and Antithrombotic Medicines

ed in Rheumatoid Disorders - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs B. Section 10.5.1 - Cardiovascular medicines- Antiplatelet and Antithrombotic Medicines

Medicine Level of 5.2.2 Ibuprofen* P,S,T Tablet 200 mg Tablet 400 mg Oral liquid 100 mg/5 mL (p) 5.2.3 Paracetamol** P,S,T Tablet 500 mg Tablet 650 mg Oral liquid 120 mg/5mL (p) Oral Liquid 125 mg/5mL (p) Oral Liquid 250 mg/5mL (p) 5.2.4 Sumatriptan P,S,T Tablet 25 mg Tablet 50 mg Section 5.2.1 - For Prophylaxis 5.2.1.1 Amitriptyline*** P,S,T Tablet 10 mg Tablet 25 mg Tablet 75 mg
*Ibuprofen formulations are also listed in Section 2.1.3 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs

**Paracetamol formulations are also listed in - A. Section 2.1.5 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory
Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Non-opioid analgesics, antipyretics and nonsteroidal anti- inflammatory medicines B. Section 27.4 - Medicines for COVID 19 management

*** Amitriptyline formulations are also listed in - A. Section 7.4.2 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care- B.

** Amitriptyline formulations are also listed in - A. Section 7.4.2 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care- B. Section 23.2.1.1 - Medicines used in treatment of Psychiatric Disorders -Medicines used in mood disorders- Medicines used in depressive disorders

Medicine Level of 5.2.1.2 Flunarizine P,S,T Tablet 5 mg Tablet 10 mg 5.2.1.3 Propranolol P,S,T Tablet 10 mg Tablet 20 mg Tablet 40 mg Section 5.3- Antiparkinsonism Medicines

Medicine Level of 5.3.1 Levodopa (A) +
Carbidopa (B) P,S,T Tablet 100 mg (A) + 10 mg (B) Tablet 100 mg (A) + 25 mg (B)
Tablet 250 mg (A) + 25 mg (B) Modified Release - Tablet 100 mg (A) + 25 mg (B) Tablet 200 mg (A) + 50 mg (B) 5.3.2 Trihexyphenidyl P,S,T Tablet 2 mg Section 5.4-Medicines used in Dementia

Medicine Level of 5.4.1 Donepezil S,T Tablet 5 mg Tablet 10 mg

Section 6 Anti-infective Medicines 6.1-Anthelminthics 6.1.1- Intestinal Anthelminthics

Medicine Level of 6.1.1.1 Albendazole* P,S,T Tablet 400 mg Chewable Tablet 400 mg Oral liquid 200 mg/5 mL (p) 6.1.1.2 Mebendazole P,S,T Tablet 100 mg Oral liquid 100 mg/5 mL (p) 6.1.2 Antifilarial

Medicine Level of 6.1.2.1 Albendazole* P,S,T Tablet 400 mg Chewable Tablet 400 mg Oral liquid 200 mg/5 mL (p) 6.1.2.2 Diethylcarbamazine (DEC) P,S,T Tablet 50 mg Tablet 100 mg Oral liquid 120 mg/5 mL (p)

Albendazole formulations are also listed Section 6.1.1.1 - in Anti-infective Medicines- Antifilarial

Diethylcarbamazine (DEC) P,S,T Tablet 50 mg Tablet 100 mg Oral liquid 120 mg/5 mL (p)

Albendazole formulations are also listed Section 6.1.1.1 - in Anti-infective Medicines- Antifilarial

Medicine Level of 6.1.2.3 Ivermectin P,S,T Tablet 6 mg Tablet 12 mg 6.1.3 - Anti-schistosomal and Anti-trematodal Medicine

Medicine Level of 6.1.3.1 Praziquantel S,T Tablet 600 mg 6.2-Antibacterials 6.2.1 Beta-lactam Medicines

Medicine Level of 6.2.1.1 Amoxicillin P,S,T Capsule 250 mg Capsule 500 mg Oral liquid 125 mg/5 mL (p) Oral liquid 250 mg/5 mL (p) Powder for Injection 250 mg Powder for Injection 500 mg Powder for injection 1000 mg 6.2.1.2 Amoxicillin (A) + Clavulanic acid (B) P,S,T Tablet 500 mg (A) + 125 mg (B) Oral liquid 200 mg (A) + 28.5 mg (B)/5 mL (p) Dry Syrup 125 mg (A) + 31.25 (B)/ 5 mL (p) S,T Powder for Injection 500 mg (A)

100 mg (B) Powder for Injection 1 g (A) + 200 mg (B)

Medicine Level of 6.2.1.3 Ampicillin P,S,T Powder for Injection 1000 mg 6.2.1.4 Benzathine benzylpenicillin P,S,T Powder for Injection 6 lac units Powder for Injection 12 lac units Powder for injection 24 lac units 6.2.1.5 Benzylpenicillin P,S,T Powder for injection 5 lac units Powder for injection 10 lac units 6.2.1.6 Cefadroxil P,S,T Tablet 500 mg Tablet 100 mg Oral liquid 125 mg/5 mL (p) 6.2.1.7 Cefazolin P,S,T 6.2.1.8 Cefixime S,T Tablet 200 mg Tablet 400 mg Oral liquid 50 mg/5 mL (p) Oral liquid 100 mg/5 mL (p) 6.2.1.9 Cefotaxime* S,T Powder for Injection 250 mg

(p) 6.2.1.7 Cefazolin P,S,T 6.2.1.8 Cefixime S,T Tablet 200 mg Tablet 400 mg Oral liquid 50 mg/5 mL (p) Oral liquid 100 mg/5 mL (p) 6.2.1.9 Cefotaxime* S,T Powder for Injection 250 mg
*Cefotaxime formulations are also listed in Section 6.7.5.2 - Anti-infective Medicines- Antiviral Medicines- Medicines for treating Opportunistic Infections in People living with HIV

Medicine Level of 6.2.1.10 Ceftazidime S,T Powder for Injection 250 mg
6.2.1.11 Ceftriaxone S,T Powder for Injection 250 mg
Powder for Injection 2000 mg 6.2.1.12 Cloxacillin P,S,T Capsule 250 mg Capsule 500 mg Oral Liquid 125 mg/5 mL (p) Powder for Injection 250 mg 6.2.1.13 Piperacillin (A) + Tazobactam (B) T (A) + 125 mg (B) Powder for Injection 2000 mg (A) + 250 mg (B) Powder for Injection 4000 mg (A) + 500 mg (B) 6.2.1.14 Meropenem T Powder for Injection 500 mg (as trihydrate) (as trihydrate)
6.2.2 - Other Antibacterials

Medicine Level of 6.2.2.1 Azithromycin* P,S,T Tablet 250 mg Tablet 500 mg Oral liquid 200 mg/5 mL (p) 6.2.2.2 Cefuroxime P,S,T

Tablet 500 mg Oral liquid 125 mg/ 5 mL (p) Injection 1500 mg
*Azithromycin formulations are also listed in Section 6.7.6.1 Anti-infective Medicines - Medicines used in the management of HIV- Additional Medicines for Syndromic Management of Sexually Transmitted Infections

formulations are also listed in Section 6.7.6.1 Anti-infective Medicines - Medicines used in the management of HIV- Additional Medicines for Syndromic Management of Sexually Transmitted Infections

Medicine Level of 6.2.2.3 Ciprofloxacin* P,S,T Tablet 250 mg Tablet 500 mg Oral liquid 250 mg/ 5 mL (p) Injection 200 mg/ 100 mL 6.2.2.4 Clarithromycin** S,T Tablet 250 mg Tablet 500 mg Oral liquid 125 mg/5 mL (p) 6.2.2.5 Clindamycin*** P,S,T Capsule 150 mg Capsule 300 mg Injection 150 mg /mL 6.2.2.6 Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)]**** P,S,T Tablet 400 mg (A) + 80 mg (B) Tablet 800 mg (A) + 160 mg (B) Oral liquid 200 mg (A) + 40 mg
(B)/5 mL (p)

Ciprofloxacin formulations are also listed in -
A. Section 16.2 - Ear, Nose and ThroatMedicines,
B. Section 21.1.2 - Ophthalmological Medicines- Anti-infective Medicines,
** Clarithromycin formulations are also listed in Section 6.4.3 - Anti-infective medicines-
Anti-tuberculosis Medicines
***Clindamycin formulations are also listed in - A. Section 6.7.5.3 - Anti-infective Medicines- Antiviral Medicines- Medicines for treating Opportunistic Infections in People living with HIV
B. Section 6.9.3.1 - Anti-infective Medicines- Drugs for amoebiasis and other parasitic infections -Antipneumocystosis and antitoxoplasmosis medicines
C.

tic Infections in People living with HIV
B. Section 6.9.3.1 - Anti-infective Medicines- Drugs for amoebiasis and other parasitic infections -Antipneumocystosis and antitoxoplasmosis medicines
C. Section 6.10.1.5 - Anti-infective Medicines- Antimalarial medicines- For curative treatment
**** Co-trimoxazole formulations are also listed in Section 6.9.3.2 - Anti-infective Medicines- Medicines for amoebiasis and other parasitic infections -Antipneumocystosis and antitoxoplasmosis medicines

Medicine Level of 6.2.2.7 Doxycycline* P,S,T Capsule 100 mg Dry Syrup 50 mg/5 mL (p) Power for Injection 100 mg 6.2.2.8 Gentamicin P,S,T Injection 10 mg/mL Injection 40 mg/mL 6.2.2.9 Metronidazole** P,S,T Tablet 200 mg Tablet 400 mg Oral liquid 200 mg/5 mL (p) Injection 500 mg/100 mL 6.2.2.10 Nitrofurantoin P,S,T
Tablet 100 mg Oral liquid 25 mg/5 mL (p) 6.2.2.11 Phenoxymethyl penicillin P,S,T Tablet 250 mg 6.2.2.12 Procaine Benzylpenicillin P,S,T Powder for injection
1000 mg (=1 million IU) 6.2.2.13 Vancomycin S,T
Capsule 125 mg Capsule 250 mg Powder for Injection 250 mg *Doxycycline formulations are also listed in Section 6.10.2.1 - Anti-infective Medicines- Antimalarial medicines- For prophylaxis
**Metronidazole formulations are also listed in Section 6.9.1.1 - Anti-infective Medicines - Antiprotozoal Medicines - Medicines for amoebiasis and other parasitic infections

nes- For prophylaxis
**Metronidazole formulations are also listed in Section 6.9.1.1 - Anti-infective Medicines - Antiprotozoal Medicines - Medicines for amoebiasis and other parasitic infections

6.3 - Antileprosy Medicines

Medicine Level of 6.3.1 Clofazimine* P,S,T Capsule 50 mg Capsule 100 mg 6.3.2 Dapsone P,S,T Tablet 50 mg Tablet 100 mg 6.3.3 Rifampicin** P,S,T Capsule 150 mg Capsule 300 mg 6.4-Antituberculosis Medicines

Medicine Level of 6.4.1 Amikacin S,T Injection 100 mg/mL Injection 250 mg/mL Injection 500 mg/mL 6.4.2 Bedaquiline T Tablet 100 mg 6.4.3 Clarithromycin*** S,T Tablet 250 mg
Tablet 500 mg
Tablet 750 mg *Clofazimine formulations are also listed Section 6.4.5 - Anti-infective Medicines -
Anti-tuberculosis medicines

**Rifampicin formulations are also listed in Section 6.4.15 - Anti-infective Medicines - Anti-tubercular medicine
***Clarithromycin formulations are also listed in Section 6.2.2.4 - Anti-infective Medicines- Antibacterials -Other Antibacterials

n 6.4.15 - Anti-infective Medicines - Anti-tubercular medicine
***Clarithromycin formulations are also listed in Section 6.2.2.4 - Anti-infective Medicines- Antibacterials -Other Antibacterials

Medicine Level of 6.4.4 Clofazimine* S,T Capsule 50 mg Capsule 100 mg 6.4.5 Cycloserine S,T Capsule 125 mg Capsule 250 mg 6.4.6 Delamanid T Tablet 50 mg 6.4.7 Ethambutol P,S,T Tablet 200 mg Tablet 400 mg Tablet 600 mg Tablet 800 mg 6.4.8 Ethionamide S,T Tablet 125 mg Tablet 250 mg 6.4.9 Isoniazid P,S,T Tablet 100 mg Tablet 300 mg Oral Liquid 50 mg/5 mL (p) 6.4.10 Levofloxacin P,S,T Tablet 250 mg Tablet 500 mg Tablet 750 mg 6.4.11 Linezolid P,S,T Tablet 300 mg Tablet 600 mg 6.4.12 Moxifloxacin P,S,T Tablet 400 mg *Clofazimine formulations are also listed in Section 6.3.1 - Anti-infective Medicines -
Antileprosy medicines

Medicine Level of 6.4.13 Para-
aminosalicylic acid S,T Granules (As licensed)
6.4.14 Pyrazinamide P,S,T Tablet 500 mg Tablet 750 mg Tablet 1000 mg Tablet 1500 mg Oral liquid 250 mg/5 mL (p) 6.4.15 Rifampicin* P,S,T Capsule 150 mg Capsule 300 mg Capsule 450 mg Capsule 600 mg Oral liquid 100 mg/ 5 mL (p) 6.4.16 Streptomycin P,S,T Powder for Injection 750 mg

6.5 - Antifungal Medicines

Medicine Level of 6.5.1 Amphotericin B** S,T a) Amphotericin B (conventional) - Injection 50 mg/vial b) Lipid Amphotericin B - Injection 50 mg/vial c) Liposomal Amphotericin B - Injection 50 mg/vial

el of 6.5.1 Amphotericin B** S,T a) Amphotericin B (conventional) - Injection 50 mg/vial b) Lipid Amphotericin B - Injection 50 mg/vial c) Liposomal Amphotericin B - Injection 50 mg/vial

*Rifampicin formulations are also listed in Section 6.3.3 - Anti-infective Medicines-
Antileprosy medicines **Amphotericin B formulations are also listed Section 6.9.2.1 - Anti-infective Medicines Antileishmaniasis medicines

Medicine Level of 6.5.2 Clotrimazole* P,S,T Pessary 100 mg 6.5.3 Fluconazole

P,S,T Tablet 50 mg Tablet 100 mg Tablet 150 mg Tablet 200 mg Tablet 400 mg Oral liquid 50 mg/ 5 mL (p) S,T Injection 200 mg / 100 mL 6.5.4 Griseofulvin P,S,T Tablet 125 mg Tablet 250 mg Tablet 375 mg 6.5.5 Itraconazole S,T Capsule 100 mg
Capsule 200 mg Oral liquid 10 mg/mL
6.5.6 Mupirocin P,S,T Ointment 2%
6.5.7 Nystatin S,T Pessary 1 Lac IU Oral Liquid 1 Lac IU/mL (p) 6.5.8 Terbinafine P,S,T Cream 1%
*Clotrimazole formulations are also listed in -
A. Section 6.7.5.4 - Anti-infective Medicines Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV
B. Section 11.1.1 - Dermatological Medicines (Topical)- Antifungal medicines
C. Section 16.3 - Ear, Nose and Throat Medicines

nes for treating Opportunistic Infections in People living with HIV
B. Section 11.1.1 - Dermatological Medicines (Topical)- Antifungal medicines
C. Section 16.3 - Ear, Nose and Throat Medicines

6.6 - Antiviral Medicines 6.6.1 - Antiherpes Medicines

Medicine Level of 6.6.1.1 Acyclovir* P,S,T

Tablet 200 mg Tablet 400 mg Tablet 800 mg Powder for Injection 250 mg
Oral liquid 400 mg/5 mL (p)

6.6.2 - Anti-cytomegalovirus (CMV) medicines

Medicine Level of 6.6.2.1 Valganciclovir** S, T Tablet 450 mg Powder for oral solution 50 mg/mL 6.7- Medicines used in the Management of HIV 6.7.1 Nucleoside Reverse Transcriptase Inhibitors

Medicine Level of 6.7.1.1 Abacavir S,T Tablet 60 mg (p) Tablet 300 mg *Acyclovir formulations are also listed in -
A. Section 6.7.5.1 - Anti-infective Medicines -Medicines used in the management of HIV - Medicines for treating Opportunistic Infections in People living with HIV
B. Section 21.1.1 - Ophthalmological Medicines- Anti-infective medicine
**Valganciclovir formulations are also listed in Section 6.7.5.5 - Anti-infective Medicines- Antiviral medicines -Medicines for treating Opportunistic Infections in People living with HIV

medicine
**Valganciclovir formulations are also listed in Section 6.7.5.5 - Anti-infective Medicines- Antiviral medicines -Medicines for treating Opportunistic Infections in People living with HIV

Medicine Level of 6.7.1.2 Abacavir (A) + Lamivudine (B)
S,T Tablet 60 mg (A) + 30 mg (B) (p) Tablet 600 mg (A) + 300 mg (B) 6.7.1.3 Lamivudine S,T Tablet 100 mg
Tablet 150 mg 6.7.1.4 Tenofovir Disproxil Fumarate (TDF)* S,T Tablet 300 mg 6.7.1.5 Tenofovir Disproxil Fumarate (A) + Lamivudine (B) S,T Tablet 300 mg (A) + 300 mg (B) 6.7.1.6 Tenofovir Disproxil Fumarate (A) + Lamivudine (B) + Dolutegravir (C) P,S,T Tablet 300 mg (A) + 300 mg (B)

50 mg (C)
6.7.1.7 Tenofovir Disproxil Fumarate (A) + Lamivudine (B) + Efavirenz (C) S,T Tablet 300 mg (A) + 300 mg (B)
600 mg (C) 6.7.1.8 Zidovudine S,T Tablet 300 mg Oral liquid 50 mg/5 mL (p) 6.7.1.9 Zidovudine (A) + Lamivudine (B) S,T Tablet 60 mg (A) + 30 mg (B) (p) Tablet 300 mg (A) + 150 mg (B)

Tenofovir Disproxil Fumarate formulations are also listed in Section 6.8.6 -
Anti-infective Medicines Medicines used in Hepatitis B and Hepatitis C

0 mg (B) (p) Tablet 300 mg (A) + 150 mg (B)

Tenofovir Disproxil Fumarate formulations are also listed in Section 6.8.6 -
Anti-infective Medicines Medicines used in Hepatitis B and Hepatitis C

Medicine Level of 6.7.1.10 Zidovudine (A) + Lamivudine (B) + Nevirapine (C) S,T Tablet 60 mg (A) + 30 mg (B) + 50 mg (C) (p) Tablet 300 mg (A) + 150 mg (B)

200 mg (C)
6.7.2 Non-nucleoside Reverse Transcriptase Inhibitors

Medicine Level of 6.7.2.1 Efavirenz S,T Tablet 200 mg (p) Tablet 600 mg 6.7.2.2 Nevirapine P,S,T Tablet 200 mg Dispersible Tablet 50 mg (p) Oral liquid 50 mg/ 5 mL (p) 6.7.3 Integrase Inhibitors

Medicine Level of 6.7.3.1 Dolutegravir S,T Tablet 50 mg
6.7.3.2 Raltegravir S,T Tablet 400 mg 6.7.4 Protease Inhibitors

Medicine Level of 6.7.4.1 Atazanavir (A) + Ritonavir (B) S,T Tablet 300 mg (A) +
Tablet 100 mg (B)

Medicine Level of 6.7.4.2 Darunavir S,T Tablet 600 mg 6.7.4.3 Darunavir (A) + Ritonavir (B) S,T Tablet 600 mg (A) +
Tablet 100 mg (B) 6.7.4.4 Lopinavir (A) + Ritonavir (B) S,T Tablet 100 mg (A) + 25 mg (B)
Tablet 200 mg (A) + 50 mg (B) Oral Liquid 80 mg (A) +
20 mg (B) /mL (p) Capsule/ Sachet (containing pellets/granules) 40 mg (A) + 10 mg (B) (p) 6.7.4.5 Ritonavir S,T Tablet 100 mg 6.7.5 Medicines for treating Opportunistic Infections in People living with HIV

Medicine Level of 6.7.5.1 Acyclovir* P,S,T Injection 250 mg 6.7.5.2 Cefotaxime** P,S,T Injection 1000 mg 6.7.5.3 Clindamycin*** P,S,T Tablet 300 mg *Acyclovir formulations are also listed in -

e Level of 6.7.5.1 Acyclovir* P,S,T Injection 250 mg 6.7.5.2 Cefotaxime** P,S,T Injection 1000 mg 6.7.5.3 Clindamycin*** P,S,T Tablet 300 mg *Acyclovir formulations are also listed in -
A. Section 6.6.1.1 - Anti-infective Medicines -Antiviral medicines -Anti-herpes medicines
B. Section 21.1.1 - Ophthalmological Medicines- Anti-infective Medicine
** Cefotaxime formulations are also listed in Section 6.2.1.9 - Anti-infective Medicines - Antibacterials- Beta-Lactam medicines

***Clindamycin formulations are also listed in -A. Section 6.2.2.5 - Anti-infective Medicines

Antibacterials -Other antibacterials
B. Section 6.9.3.1 - Anti-infective Medicines - Medicines for amoebiasis and other parasitic infections - Antipneumocystosis and antitoxoplasmosis medicines C. Section 6.10.1.5 - Anti-infective Medicines - Antimalarial medicines- For curative treatment

Medicine Level of 6.7.5.4 Clotrimazole* P,S,T Ointment 1 % 6.7.5.5 Valganciclovir** S,T Tablet/Capsule 450 mg 6.7.6 Additional Medicines for Syndromic Management of Sexually Transmitted Infections

Medicine Level of 6.7.6.1 Azithromycin*** P,S,T Tablet 1000 mg Section 6.8 -Medicines used in Hepatitis B and Hepatitis C

Medicine Level of 6.8.1 Daclatasvir S,T Tablet 30 mg Tablet 60 mg 6.8.2 Entecavir S,T Tablet 0.5 mg Tablet 1 mg Oral liquid 0.05 mg/mL (p) *Clotrimazole formulations are also listed in -
A. Section 6.5.2 - Anti-infective Medicines -Antifungal medicines
B. Section 11.1.1 - Dermatological Medicines (Topical)- Antifungal medicines
C.

*Clotrimazole formulations are also listed in -
A. Section 6.5.2 - Anti-infective Medicines -Antifungal medicines
B. Section 11.1.1 - Dermatological Medicines (Topical)- Antifungal medicines
C. Section 16.3 - Ear, Nose and Throat Medicines
**Valganciclovir formulations are also listed in Section 6.6.2.1 - Anti-infective Medicines - Antiviral medicines -Anti Cytomegalovirus (CMV) medicines ***Azithromycin formulations are also listed in Section 6.2.2.1 - Anti-infective Medicines - Other antibacterials

Medicine Level of 6.8.3 Ribavirin S,T Capsule 200 mg 6.8.4 Sofosbuvir S,T Tablet 400 mg 6.8.5 Tenofovir Alafenamide Fumarate (TAF) S,T Tablet 25 mg 6.8.6 Tenofovir Disproxil Fumarate (TDF)* S,T Tablet 300 mg Section 6.9 -Antiprotozoal Medicines 6.9.1 - Medicines for Amoebiasis and other Parasitic Infections

Medicine Level of 6.9.1.1 Metronidazole** P,S,T Tablet 200 mg Tablet 400 mg Injection 500 mg/100 mL
Oral liquid 200 mg/5 mL (p)

Tenofovir Disproxil Fumarate formulations are also listed in Section 6.7.1.4 -
Anti-infective Medicines Medicines used in the management of HIV- Nucleoside reverse transcriptase inhibitors

** Metronidazole formulations are also listed in Section 6.2.2.9 - Anti-infective Medicines - Antibacterials Beta-lactam medicines - Other antibacterials

side reverse transcriptase inhibitors

** Metronidazole formulations are also listed in Section 6.2.2.9 - Anti-infective Medicines - Antibacterials Beta-lactam medicines - Other antibacterials

6.9.2 - Antileishmaniasis Medicines

Medicine Level of 6.9.2.1 Amphotericin B* S,T a) Amphotericin B (conventional)- Injection 50 mg b) Lipid Amphotericin B- Injection 50 mg c) Liposomal Amphotericin B- Injection 50 mg 6.9.2.2 Miltefosine P,S,T Capsule 50 mg
6.9.2.3 Paromomycin P,S,T Injection 375 mg/mL 6.9.3 - Antipneumocystosis and Antitoxoplasmosis Medicines

Medicine Level of 6.9.3.1 Clindamycin** P,S,T Capsule 150 mg Capsule 300 mg *Amphotericin B formulations are also listed in Section 6.5.1 - Anti-infective Medicines- Antifungal medicines **Clindamycin formulations are also listed in -
A. Section 6.2.2.5 - Anti-infective Medicines - Antibacterials -Other antibacterials
B. Section 6.7.5.3 - Anti-infective Medicines - Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV
C. Section 6.10.1.5 - Anti-infective Medicines- Antimalarial Medicines - For curative treatment

s - Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV
C. Section 6.10.1.5 - Anti-infective Medicines- Antimalarial Medicines - For curative treatment

Medicine Level of 6.9.3.2 Co-trimoxazole* [Sulphamethoxazole (A) + Trimethoprim (B)] P,S,T Tablet 400 mg (A) + 80 mg (B) Tablet 800 mg (A) + 160 mg (B) Oral liquid 200 mg (A) +
40 mg (B)/5 mL (p) 6.10-Antimalarial Medicines 6.10.1 - For curative treatment

Medicine Level of 6.10.1.1 Artemether (A) + Lumefantrine (B) P,S,T Tablet 20 mg (A) + 120 mg (B) Tablet 40 mg (A) + 240 mg (B) Tablet 80 mg (A) + 480 mg (B)
6.10.1.2 Artesunate P,S,T Powder for Injection 60 mg
Powder for Injection 120 mg 6.10.1.3 Artesunate (A) + Sulphadoxine - Pyrimethamine (B) P,S,T Combi pack (A+B) 1 Tablet 25 mg (A) + 1 Tablet (250 mg + 12.5 mg) (B) 1 Tablet 50 mg (A) + 1 Tablet (500 mg + 25 mg) (B) 1 Tablet 100 mg (A) + 1 Tablet (750 mg + 37.5 mg) (B) 1 Tablet 150 mg (A) + 2 Tablet (500 mg + 25 mg) (B) 1 Tablet 200 mg (A) + 2 Tablet (750 mg + 37.5 mg) (B)

*Co-trimoxazole formulations are also listed in Section 6.2.2.6 - Anti-infective Medicines- Antibacterials - Other antibacterials

5 mg) (B) 1 Tablet 200 mg (A) + 2 Tablet (750 mg + 37.5 mg) (B)

*Co-trimoxazole formulations are also listed in Section 6.2.2.6 - Anti-infective Medicines- Antibacterials - Other antibacterials

Medicine Level of 6.10.1.4 Chloroquine P,S,T Tablet 150 mg Oral liquid 50 mg/5 mL 6.10.1.5 Clindamycin*
P,S,T Capsule 150 mg Capsule 300 mg 6.10.1.6 Primaquine P,S,T Tablet 2.5 mg Tablet 7.5 mg Tablet 15 mg 6.10.1.7 Quinine P,S,T Tablet 300 mg Injection 300 mg/mL 6.10.2 - For prophylaxis

Medicine Level of 6.10.2.1 Doxycycline**# P,S,T Capsule 100 mg Oral liquid 50 mg/ 5mL #for prophylaxis of P. vivax 6.10.2.2 Mefloquine# T Tablet 250 mg #Only for use as chemoprophylaxis for long term travellers like military and travel troops, travelling from low endemic to high endemic area.

Clindamycin formulations are also listed in -
A. Section 6.2.2.5 - Anti-infective Medicines - Antibacterials -Other antibacterials
B. Section 6.7.5.3 - Anti-infective Medicines - Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV
C. Section 6.9.3.1 - Anti-infective Medicines - Antipneumocystosis and antitoxoplasmosis medicines
** Doxycycline formulations are also listed in Section 6.2.2.7 - Anti-infective Medicines- Antibacterials - Other antibacterials

ve Medicines - Antipneumocystosis and antitoxoplasmosis medicines
** Doxycycline formulations are also listed in Section 6.2.2.7 - Anti-infective Medicines- Antibacterials - Other antibacterials

Section 7 Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care 7.1 - Antineoplastic medicines

Medicine Level of 7.1.1 5-Fluorouracil T Injection 250 mg/ 5 mL 7.1.2 6-Mercaptopurine T Tablet 50 mg 7.1.3 Actinomycin D T Powder for Injection 0.5 mg 7.1.4 All-trans retinoic acid T Capsule 10 mg 7.1.5 Arsenic trioxide T Injection 1mg/ mL 7.1.6 Bendamustine hydrochloride T Injection 25 mg/ vial Injection 100 mg/vial
7.1.7 Bleomycin T Powder for Injection 15 units 7.1.8 Bortezomib T Powder for Injection 2 mg 7.1.9 Calcium folinate T Tablet 15 mg Injection 3 mg/mL 7.1.10 Capecitabine T Tablet 500 mg

Medicine Level of 7.1.11 Carboplatin T Injection 10 mg/mL
7.1.12 Chlorambucil T Tablet 2 mg Tablet 5 mg 7.1.13 Cisplatin T Injection 1mg/mL 7.1.14 Cyclophosphamide T Tablet 50 mg 7.1.15 Cytosine arabinoside T Injection 100 mg/vial
Injection 500 mg/vial Injection 1000 mg/vial 7.1.16 Dacarbazine T Powder for Injection 200 mg
7.1.17 Daunorubicin T Injection 5 mg/mL 7.1.18 Docetaxel T Powder for Injection 20 mg
Powder for Injection 80 mg 7.1.19 Doxorubicin T Injection 2 mg/mL 7.1.20 Etoposide T Capsule 50 mg Injection 20 mg/mL 7.1.21 Gefitinib T Tablet 250 mg

el T Powder for Injection 20 mg
Powder for Injection 80 mg 7.1.19 Doxorubicin T Injection 2 mg/mL 7.1.20 Etoposide T Capsule 50 mg Injection 20 mg/mL 7.1.21 Gefitinib T Tablet 250 mg

Medicine Level of 7.1.22 Gemcitabine T

Powder for Injection 200 mg
7.1.23 Hydroxyurea* T Capsule 500 mg 7.1.24 Ifosfamide T Powder for Injection 2000 mg 7.1.25 Imatinib T Tablet 100 mg Tablet 400 mg 7.1.26 Irinotecan HCl trihydrate T Solution for injection 20 mg/ mL 7.1.27 L-Asparaginase T Powder for Injection 5000 KU
Powder for Injection 10000 KU 7.1.28 Lenalidomide T Capsule 5 mg Capsule 25 mg
7.1.29 Melphalan T Tablet 2 mg Tablet 5 mg 7.1.30 Methotrexate** S,T Tablet 2.5 mg Tablet 5 mg
Tablet 10 mg Injection 50 mg/mL
*Hydroxyurea formulations are also listed in Section 8.1.6 - Medicines affecting Blood
Antianaemia Medicines
**Methotrexate formulations are also listed in Section 2.4.3 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Disease Modifying Agents used in Rheumatoid Disorders

ics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Disease Modifying Agents used in Rheumatoid Disorders

Medicine Level of 7.1.31 Oxaliplatin T Injection 5 mg/mL in 10 mL vial Injection 5 mg/mL in 20 mL vial 7.1.32 Paclitaxel T Injection 30 mg/5 mL Injection 100 mg/16.7 mL 7.1.33 Rituximab T Injection 10 mg/mL 7.1.34 Temozolomide T Capsule 20 mg Capsule 100 mg Capsule 250 mg 7.1.35 Thalidomide T Capsule 50 mg Capsule 100 mg 7.1.36 Trastuzumab T Injection 440 mg/50 mL 7.1.37 Vinblastine T Injection 1 mg/mL 7.1.38 Vincristine T Injection 1 mg/mL 7.2-Hormones and Anti-hormones used in Cancer Therapy Medicine Level of 7.2.1 Bicalutamide T Tablet 50 mg 7.2.2 Letrozole T Tablet 2.5 mg

Medicine Level of 7.2.3 Leuprolide acetate
T Powder for injection 3.75 mg Powder for injection 11.25 mg Powder for injection 22.5 mg
7.2.4 Prednisolone* S,T Tablet 10 mg Tablet 20 mg Tablet 40 mg Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p) Injection 20 mg/2 mL 7.2.5 Tamoxifen T Tablet 10 mg Tablet 20 mg 7.3 - Immunosuppressive Medicines Medicine Level of 7.3.1 Azathioprine** T Tablet 50 mg 7.3.2 Cyclosporine T Capsule 25 mg Capsule 50 mg Capsule 100 mg Oral liquid 100 mg/mL (p) Injection 50 mg/mL *Prednisolone formulations are also listed in -
A. Section 3.6 - Antiallergics and Medicines used in Anaphylaxis
B.

Capsule 50 mg Capsule 100 mg Oral liquid 100 mg/mL (p) Injection 50 mg/mL *Prednisolone formulations are also listed in -
A. Section 3.6 - Antiallergics and Medicines used in Anaphylaxis
B. Section 18.1.5 - Hormones, other Endocrine Medicines and Contraceptives -Adrenal Hormones and synthetic substitutes
C. Section 21.2.1 - Ophthalmological Medicines - Antiinflammatory Medicine

**Azathioprine formulations are also listed in Section 2.4.1 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Disease Modifying Agents used in Rheumatoid Disorders

Medicine Level of 7.3.3 Mycophenolate mofetil T Tablet 250 mg Tablet 500 mg 7.3.4 Tacrolimus T Capsule 0.5 mg Capsule 1 mg Capsule 2 mg 7.4-Medicines used in Palliative Care Medicine Level of 7.4.1 Allopurinol* S,T Tablet 100 mg 7.4.2 Amitriptyline** S,T Tablet 10 mg Tablet 25 mg 7.4.3 Dexamethasone*** S,T Tablet 0.5 mg Tablet 4 mg Injection 4 mg/mL *Allopurinol formulations are also listed in Section 2.3.1 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs),Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Medicines used to treat Gout

**Amitriptyline formulations are also listed in A. Section 5.2.5 - Medicines used in Neurological Disorders - Anti-migraine medicines -
For prophylaxis
B.

ders - Medicines used to treat Gout

**Amitriptyline formulations are also listed in A. Section 5.2.5 - Medicines used in Neurological Disorders - Anti-migraine medicines -
For prophylaxis
B. Section 23.2.1.1 - Medicines in treatment of Psychiatric Disorders -Medicines used in mood disorders- Medicines used in depressive disorders

***Dexamethasone formulations are also listed in A. Section 3.4 - Antiallergics and medicines used in anaphylaxis
B. Section 18.1.1 - Hormones, other Endocrine Medicines and Contraceptives - Adrenal hormones and synthetic substitutes
C. Section 27.1 - Medicines for COVID 19 management

Medicine Level of 7.4.4 Diazepam* S,T Tablet 2 mg Tablet 5 mg Injection 5 mg/mL 7.4.5 Filgrastim T Injection 300 mcg 7.4.6 Fluoxetine** S,T Capsule 20 mg 7.4.7 Haloperidol*** S,T Tablet 1.5 mg Tablet 5 mg Injection 5 mg/mL 7.4.8 Lactulose**** S,T Oral liquid 10 g/15 mL
7.4.9 Loperamide S,T Tablet 2 mg *Diazepam formulations are also listed Section 5.1.3 - Medicines used in Neurological Disorders - Anticonvulsants/Antiepileptics **Fluoxetine formulations are also listed in A. Section 23.2.1.3 - Medicines in used in treatment of Psychiatric Disorders - Medicines used in mood disorders - Medicines used in depressive disorders
B.

xetine formulations are also listed in A. Section 23.2.1.3 - Medicines in used in treatment of Psychiatric Disorders - Medicines used in mood disorders - Medicines used in depressive disorders
B. Section 23.4.2 - Medicines used in treatment of Psychiatric Disorders - Medicines used in obsessive compulsive disorders and panic attacks
***Haloperidol formulations are also listed in Section 23.1.3 -
Medicines used in treatment of psychiatric Disorders - Medicines used in psychotic disorders
****Lactulose formulations are also listed in Section 17.5.3 -
Gastrointestinal Medicines - Laxatives

Medicine Level of 7.4.10 Metoclopramide*

S,T

Tablet 10 mg Oral liquid 5 mg/5 mL (p) Injection 5 mg/mL 7.4.11 Mesna T Injection 100 mg/mL 7.4.12 Midazolam** S,T Injection 1 mg/mL 7.4.13 Morphine*** S,T Tablet 10 mg Modified Release Tablet 30 mg 7.4.14 Ondansetron**** S,T Tablet 4 mg Tablet 8 mg Oral liquid 2 mg/5 mL (p) Injection 2 mg/mL *Metoclopramide formulations are also listed in Section 17.2.2 - Gastrointestinal Medicines Antiemetics **Midazolam formulations are also listed in -
A. Section 1.3.3 - Medicines used in Anaesthesia - Preoperative medication and sedation for short term procedures
B. Section 5.1.7 - Medicines used in Neurological Disorders -Anticonvulsants/Antiepileptics

***Morphine formulations are also listed in - A. Section 1.3.4 - Medicines used in Anaesthesia - Preoperative medication and sedation for short term procedures
B.

ticonvulsants/Antiepileptics

***Morphine formulations are also listed in - A. Section 1.3.4 - Medicines used in Anaesthesia - Preoperative medication and sedation for short term procedures
B. Section 2.2.2 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Opioid Analgesics ****Ondansetron formulations are also listed Section 17.2.3 - Gastrointestinal Medicines
anti-ulcer medicines

Medicine Level of 7.4.15 Tramadol* S,T Capsule 50 mg Capsule 100 mg Injection 50 mg/mL 7.4.16 Zoledronic acid T Powder for Injection 4 mg Section 8 Medicines affecting Blood 8.1- Antianaemia Medicines

Medicine Level of 8.1.1 Erythropoietin S,T Injection 2000 IU/mL Injection 10000 IU/mL

8.1.2

Ferrous salts

(a) Iron Dextran (b) Iron sorbitol citrate complex P,S,T

Tablet equivalent to 60 mg of elemental iron Injection 50 mg/mL
Injection 50 mg/mL 8.1.3 Ferrous Salt (A)+ Folic acid (B) P,S,T Tablet 45 mg elemental iron (A)

400 mcg (B) Tablet 100 mg elemental iron (A) + 500 mcg (B) Oral liquid 20 mg elemental iron (A) + 100 mcg/mL (B) (p) *Tramadol formulations are also listed in Section 2.2.3 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders- Opioid Analgesics

Section 2.2.3 - Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders- Opioid Analgesics

Medicine Level of 8.1.4 Folic Acid P,S,T
Tablet 1 mg
Tablet 5 mg 8.1.5 Hydroxocobalamin P,S,T Injection 1 mg/mL 8.1.6 Hydroxyurea* S,T Capsule 500 mg 8.1.7 Iron sucrose S,T Injection 20 mg/mL 8.2 - Medicines affecting Coagulation

Medicine Level of 8.2.1 Enoxaparin** S,T Injection 40 mg/ 0.4 mL
Injection 60 mg/ 0.6 mL
8.2.2 Heparin*** S,T Injection 1000 IU/mL Injection 5000 IU/mL 8.2.3 Phytomenadione (Vitamin K1) P,S,T Tablet 10 mg Injection 10 mg/mL 8.2.4 Protamine Sulphate S,T Injection 10 mg/mL 8.2.5 Tranexamic acid P,S,T Tablet 500 mg Injection 100 mg/mL

Hydroxyurea formulations are also listed in Section 7.1.26 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Antineoplastic medicines

** Enoxaparin formulations are also listed in
A. Section 10.5.4 - Cardiovascular Medicines - Antiplatelet and Antithrombotic Medicines
B. Section 27.2 - Medicines for COVID 19 management

*** Heparin formulations are also listed in Section 10.5.5 - Cardiovascular Medicines - Antiplatelet and Antithrombotic Medicines

edicines
B. Section 27.2 - Medicines for COVID 19 management

*** Heparin formulations are also listed in Section 10.5.5 - Cardiovascular Medicines - Antiplatelet and Antithrombotic Medicines

Medicine Level of 8.2.6 Warfarin S,T Tablet 1 mg
Tablet 2 mg Tablet 3 mg Tablet 5 mg Section 9 Blood products and Plasma substitutes 9.1 - Blood and Blood components All forms of the following as approved by licensing authority are considered as included in NLEM. However, considering the process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc.

Medicine Level of 9.1.1 Fresh frozen plasma S,T As licensed 9.1.2 Platelet rich plasma/ Platelet concentrates S,T As licensed 9.1.3 Red blood cells/
Packed RBCs S,T As licensed 9.1.4 Whole blood S,T As licensed

9.2 - Plasma substitutes

Medicine Level of 9.2.1 Dextran-40 S,T Injection 10 % 9.3 - Plasma fractions for specific use In case of coagulation factors and other blood products, irrespective of variation in source, all forms of these products as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc.

red as included in NLEM. However, considering the source, process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc.

Medicine Level of Healthcare 9.3.1 Coagulation factor IX S,T Powder for Injection 600 IU 9.3.2 Coagulation factor VIII S,T Powder for Injection 250 IU Powder for Injection 500 IU 9.3.3 Cryoprecipitate S,T As licensed

Section 10 Cardiovascular Medicines 10.1-Medicines used in Angina

Medicine Level of Healthcare 10.1.1 Diltiazem
P,S,T Tablet 30 mg Tablet 60 mg Modified Release Tablet 180 mg S, T
Injection 5 mg/mL 10.1.2 Glyceryl trinitrate P,S,T Sublingual Tablet 0.5 mg S,T Injection 5 mg/mL 10.1.3 Isosorbide dinitrate P,S,T

Tablet 5 mg Tablet 10 mg 10.1.4 Metoprolol P,S,T Tablet 25 mg Tablet 50 mg Tablet 100 mg Modified Release Tablet 100 mg S,T Injection 1 mg/mL

10.2 - Antiarrhythmic medicines

Medicine Level of Healthcare Dosage form(s) and strength(s) 10.2.1 Adenosine S,T Injection 3 mg/mL 10.2.2 Amiodarone S,T Tablet 100 mg Tablet 200 mg Injection 50 mg/mL 10.2.3 Digoxin* S,T Tablet 0.25 mg Oral liquid 0.05 mg/mL Injection 0.25 mg/mL 10.2.4 Esmolol S,T Injection 10 mg/mL 10.2.5 Lignocaine** S,T Injection 2% 10.2.6 Verapamil S,T Tablet 40 mg Tablet 80 mg
Injection 2.5 mg/ mL 10.3 - Antihypertensive Medicines

Medicine Level of 10.3.1 Amlodipine P,S,T Tablet 2.5 mg Tablet 5 mg Tablet 10 mg

0.2.6 Verapamil S,T Tablet 40 mg Tablet 80 mg
Injection 2.5 mg/ mL 10.3 - Antihypertensive Medicines

Medicine Level of 10.3.1 Amlodipine P,S,T Tablet 2.5 mg Tablet 5 mg Tablet 10 mg *Digoxin formulations are also listed in Section 10.4.1 - Cardiovascular Medicines - Medicines used in Shock and Heart Failure **Lignocaine formulations are also listed in Section 1.2.2 - Medicines used in Anaesthesia - Local Anaesthetics

Medicine Level of 10.3.2 Enalapril P,S,T Tablet 2.5 mg Tablet 5 mg 10.3.3 Hydrochlorothiazide * P,S,T Tablet 12.5 mg Tablet 25 mg 10.3.4 Labetalol P,S,T Tablet 50 mg Tablet 100 mg P,S,T Injection 5 mg/mL
10.3.5 Ramipril P,S,T Tablet 2.5 mg Tablet 5 mg 10.3.6 Sodium nitroprusside S, T Injection 10 mg/mL
10.3.7 Telmisartan P,S,T Tablet 20 mg Tablet 40 mg Tablet 80 mg 10.4 - Medicines used in Shock and Heart failure

Medicine Level of 10.4.1 Digoxin** S,T Tablet 0.25 mg Oral liquid 0.05 mg/mL Injection 0.25 mg/mL

*Hydrochlorothiazide formulations are also listed in Section 15.2 - Diuretics

**Digoxin formulations are also listed in Section 10.2.3 - Cardiovascular Medicines - Antiarrhythmic medicines

*Hydrochlorothiazide formulations are also listed in Section 15.2 - Diuretics

**Digoxin formulations are also listed in Section 10.2.3 - Cardiovascular Medicines - Antiarrhythmic medicines

Medicine Level of 10.4.2 Dobutamine S,T Injection 50 mg/mL 10.4.3 Dopamine S,T Injection 40 mg/mL 10.4.4 Noradrenaline S,T Injection 2 mg/mL 10.4.5 Spironolactone* P,S,T Tablet 25 mg Tablet 50 mg 10.5- Antiplatelet and Antithrombotic Medicines

Medicine Level of 10.5.1 Acetylsalicylic acid** P,S,T Conventional/Effervescent/ Dispersible/ Enteric coated Tablets 150 mg
Conventional/Effervescent/ Dispersible/ Enteric coated Tablets 325 mg Enteric coated Tablet 75 mg Enteric coated Tablet 100 mg
*Spironolactone formulations are also listed in Section 15.4 - Diuretics
**Acetylsalicyclic acid formulations are also listed in -
A. Section 2.1.1 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory
Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs B. Section 5.2.1 - Medicines used in Neurological Disorders- Antimigraine medicines

s used in Rheumatoid Disorders - Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs B. Section 5.2.1 - Medicines used in Neurological Disorders- Antimigraine medicines

10.5.2 Clopidogrel P,S,T Tablet 75 mg Tablet 150 mg
10.5.3 Dabigatran S, T Tablet 110 mg Tablet 150 mg 10.5.4 Enoxaparin* S,T Injection 40 mg/ 0.4 mL Injection 60 mg/ 0.6 mL 10.5.5 Heparin** S,T Injection 1000 IU/mL Injection 5000 IU/mL 10.5.6 Streptokinase S,T Injection 750,000 IU
Injection 15,00,000 IU 10.5.7 Tenecteplase S,T Injection 30 mg/vial Injection 40 mg/vial 10.6 - Hypolipidemic Medicines

Medicine Level of 10.6.1 Atorvastatin P,S,T Tablet 10 mg Tablet 20 mg Tablet 40 mg
Tablet 80 mg

*Enoxaparin formulations are also listed in -
A. Section 8.2.1 - Medicines affecting Blood - Medicines affecting coagulation
B. Section 27.2 - Medicines for COVID 19 management

**Heparin formulations are also listed in Section 8.2.2 - Medicines affecting Blood - Medicines affecting coagulation

affecting coagulation
B. Section 27.2 - Medicines for COVID 19 management

**Heparin formulations are also listed in Section 8.2.2 - Medicines affecting Blood - Medicines affecting coagulation

Section 11 Dermatological Medicines (Topical) 11.1 - Antifungal Medicines

Medicine Level of 11.1.1 Clotrimazole* P,S,T Cream 1 % Lotion 1 % 11.2 - Antibacterial Medicines

Medicine Level of 11.2.1 Framycetin P,S,T Cream 1 % 11.2.2 Fusidic acid P,S,T Cream 2 % 11.2.3 Silver sulphadiazine P,S,T Cream 1 % 11.3-Antiinflammatory and Antipruritic Medicines

Medicine Level of 11.3.1 Betamethasone valerate P,S,T Cream 0.05 % Cream 0.1 % *Clotrimazole formulations are also listed in -
A. Section 6.5.2 - Anti-infective Medicines -Antifungal medicines
B. Section 6.7.5.4 - Anti-infective Medicines Antiviral medicines- Medicines used in the management of HIV C. Section 16.3 - Ear, Nose and ThroatMedicines

Medicine Level of 11.3.2 Calamine P,S,T Lotion (As per IP) 11.4 - Keratolytic agents

Medicine Level of 11.4.1 Benzoyl peroxide P,S,T Gel 2.5 % - 5 % 11.4.2 Coal tar (A) + Salicylic Acid (B) P,S,T Solution 1 % (A) + 3 % (B) 11.4.3 Podophyllin resin S,T Solution 20 % 11.4.4 Salicylic acid P,S,T Ointment 3-6 % 11.5 - Scabicides and Pediculicides

Medicine Level of 11.5.1 Permethrin P,S,T Lotion 1 % Cream 5 % 11.6 Miscellaneous

Medicine Level of 11.6.1 Glycerin/glycerol
(as mentioned in IP) P,S,T Topical

and Pediculicides

Medicine Level of 11.5.1 Permethrin P,S,T Lotion 1 % Cream 5 % 11.6 Miscellaneous

Medicine Level of 11.6.1 Glycerin/glycerol
(as mentioned in IP) P,S,T Topical

Section 12 Diagnostic agents 12.1 - Ophthalmic Medicines

Medicine Level of 12.1.1 Fluorescein S,T Ophthalmic Strips 12.1.2 Proparacaine* S,T Eye Drops 0.5% 12.1.3 Tropicamide** S,T Eye drop 1 % 12.2 - Radiocontrast Media 12.2.1 Barium sulphate S,T Oral Liquid 95% w/v 12.2.2 Gadobenate dimeglumine T Injection 529 mg/mL 12.2.3 Iohexol S,T Injection 140 to 350 mg iodine/mL 12.2.4 Meglumine diatrizoate S,T Injection 60 % w/v Injection 76 % w/v

Proparacaine formulations are also listed in Section 21.3.1 - Ophthalmological Medicines- Local Anaesthetics

** Tropicamide formulations are also listed in Section 21.5.4 - Ophthalmological Medicines Mydriatics

Section 13 Dialysis components (Haemodialysis and Peritoneal Dialysis)

Medicine Level of 13.1 Haemodialysis fluid S,T As licensed 13.2 Peritoneal dialysis solution S,T As licensed Section 14 Antiseptics and Disinfectants 14.1 Antiseptics

Medicine Level of 14.1.1 Chlorhexidine P,S,T Solution 5% (Concentrate) 14.1.2 Ethyl alcohol (Denatured) P,S,T Solution 70% 14.1.3 Hydrogen peroxide P,S,T Solution 6 % 14.1.4 Methylrosanilinium chloride
(Gentian Violet) P,S,T Topical preparation 0.25% to 2% 14.1.5 Povidone iodine* P,S,T Solution 4 % to 10 % *Povidone Iodine formulations are also listed in Section 21.1.5 - Ophthalmological

(Gentian Violet) P,S,T Topical preparation 0.25% to 2% 14.1.5 Povidone iodine* P,S,T Solution 4 % to 10 % *Povidone Iodine formulations are also listed in Section 21.1.5 - Ophthalmological Medicines - Anti-infective medicine

14.2 Disinfectants

Medicine Level of 14.2.1 Glutaraldehyde S,T As Licensed 14.2.2 Potassium permanganate P,S,T Crystals for topical solution Section 15 Diuretics

Medicine Level of 15.1 Furosemide P,S,T Tablet 40 mg Oral liquid 10 mg/mL
Injection 10 mg/ mL 15.2 Hydrochlorothiazide * P,S,T Tablet 25 mg Tablet 50 mg 15.3 Mannitol P,S,T Injection 10 % Injection 20 % 15.4 Spironolactone** P,S,T Tablet 25 mg Tablet 50 mg

Hydrochlorothiazide formulations are also listed in Section 10.3.3 - Antihypertensive Medicines **Spironolactone formulations are also listed in Section 10.4.5 - Cardiovascular Medicines - Medicines used in shock and heart failure

Section 16 Ear, Nose and Throat Medicines

Medicine Level of 16.1 Budesonide* P,S,T Nasal Spray 50 mcg/dose Nasal Spray 100 mcg/dose
16.2 Ciprofloxacin** P,S,T Drops 0.3 % 16.3 Clotrimazole*** P,S,T Drops 1 % 16.4 Xylometazoline P,S,T Nasal drops 0.05 % Nasal drops 0.1 % *Budesonide formulations are also listed in Section 24.1 - Medicines acting on the respiratory tract - Antiasthmatic Medicines
**Ciprofloxacin formulations are also listed in A. Section 6.2.2.3 - Anti-infective Medicines- Antibacterials -Other Antibacterials
B.

acting on the respiratory tract - Antiasthmatic Medicines
**Ciprofloxacin formulations are also listed in A. Section 6.2.2.3 - Anti-infective Medicines- Antibacterials -Other Antibacterials
B. Section 21.1.2 - Ophthalmological Medicines- Anti-infective Medicines
***Clotrimazole formulations are also listed in -
A. Section 6.5.2 - Anti-infective Medicines -Antifungal medicines
B. Section 6.7.5.4 - Anti-infective Medicines Antiviral medicines- Medicines used in the management of HIV C. Section 11.1.1 - Dermatological Medicines (Topical) -Antifungal medicines

Section 17 Gastrointestinal Medicines 17.1 - Antiulcer Medicines

Medicine Level of 17.1.1 Omeprazole P,S,T Capsule 10 mg Capsule 20 mg Capsule 40 mg
Powder for oral liquid 20 mg 17.1.2 Pantoprazole S,T Injection 40 mg 17.2 Antiemetics

Medicine Level of 17.2.1 Domperidone P,S,T Tablet 10 mg Oral Liquid 1 mg/mL 17.2.2 Metoclopramide* P,S,T Tablet 10 mg Injection 5 mg/mL 17.2.3 Ondansetron* S,T Tablet 4 mg Oral Liquid 2 mg/5 mL (p) Injection 2 mg/ mL *Metoclopramide formulations are also listed in Section 7.4.10 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicines used in Palliative Care *Ondansetron formulations are also listed in Section 7.4.14 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicines used in Palliative Care

iative Care *Ondansetron formulations are also listed in Section 7.4.14 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicines used in Palliative Care

17.3 Anti-inflammatory medicines

Medicine Level of 17.3.1 5-aminosalicylic acid (Mesalazine/ Mesalaine) S, T Tablet 400 mg Suppository 500 mg
Retention Enema 17.4 Antispasmodic medicines

Medicine Level of 17.4.1 Dicyclomine P,S,T Tablet 10 mg Oral Solution 10 mg/5mL Injection 10 mg/ mL 17.4.2 Hyoscine
butyl bromide P,S,T Tablet 100 mg Injection 20 mg/ mL 17.5 Laxatives

Medicine Level of 17.5.1 Bisacodyl P,S,T Tablet 5 mg Suppository 5 mg 17.5.2 Ispaghula P,S,T Granules/ Husk/ Powder

Medicine Level of 17.5.3 Lactulose* S,T Oral Liquid 10 g/15 mL 17.6 Medicines used in diarrhea

Medicine Level of 17.6.1 Oral rehydration salts** P,S,T As licensed 17.6.2 Zinc Sulphate P,S,T Dispersible Tablet 20 mg 17.7 Other medicines

Medicine Level of 17.7.1 Somatostatin T Powder for Injection 3 mg *Lactulose formulations are also listed in Section 7.4.8 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care

**Oral rehydration salts formulations are also listed in Section 25.3 - Solutions correcting water, electrolyte disturbances and acid-base disturbances

Care - Medicines used in Palliative Care

**Oral rehydration salts formulations are also listed in Section 25.3 - Solutions correcting water, electrolyte disturbances and acid-base disturbances

Section 18 Hormones, other Endocrine Medicines and Contraceptives 18.1-Adrenal Hormones and Synthetic substitutes

Medicine Level of 18.1.1 Dexamethasone* S,T Tablet 0.5 mg Injection 4 mg/mL 18.1.2 Fludrocortisone
S,T Tablet 0.1 mg 18.1.3 Hydrocortisone** P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg Powder for Injection 100 mg 18.1.4 Methylprednisolone

S,T Injection 40mg/mL *Dexamethasone formulations are also listed in -
A. Section 3.4 - Antiallergics and Medicines used in Anaphylaxis
B. Section 7.4.3 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care - Medicines used in Palliative Care
C. Section 27.1 - Medicines for COVID 19 Management

** Hydrocortisone formulations are also listed in Section 3.5 - Antiallergics and Medicines used in Anaphylaxis

*** Methylprednisolone formulations are also listed in section 27.3-
Medicines for COVID - 19 management

ations are also listed in Section 3.5 - Antiallergics and Medicines used in Anaphylaxis

*** Methylprednisolone formulations are also listed in section 27.3-
Medicines for COVID - 19 management

Medicine Level of 18.1.5 Prednisolone* P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg Oral liquid 5 mg/5 mL (p)
Oral liquid 15 mg/5 mL (p) 18.2 Contraceptives 18.2.1 - Hormonal Contraceptives

Medicine Level of 18.2.1.1 Ethinylestradiol (A)+ Levonorgestrel (B) P,S,T Tablet 0.03 mg (A) +
Tablet 0.15 mg (B) 18.2.1.2 Levonorgestrel P,S,T Tablet 0.75 mg Tablet 1.5 mg 18.2.1.3 Ormeloxifene (Centchroman) P,S,T Tablet 30 mg *Prednisolone formulations are also listed in -
A. Section 3.7 - Antiallergics and Medicines used in Anaphylaxis
B. Section 7.2.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Hormones and anti- hormones used in cancer therapy
C. Section 21.2.1 - Ophthalmological Medicines - Antiinflammatory medicine

including Immunosuppressives, and Medicines used in Palliative Care Hormones and anti- hormones used in cancer therapy
C. Section 21.2.1 - Ophthalmological Medicines - Antiinflammatory medicine

18.2.2 - Intrauterine Devices

Medicine Level of 18.2.2.1 Hormone releasing IUD T Contains 52 mg of Levonorgestrel 18.2.2.2 IUD containing Copper P,S,T As licensed 18.2.3 - Barrier methods

Medicine Level of 18.2.3.1 Condom P,S,T As Licensed as per the standards of Drugs Rules, 1945
18.3 - Medicines used in Diabetes Mellitus 18.3.1 - Insulins and other Antidiabetic agents

Medicine Level of 18.3.1.1 Glimepiride P,S,T Tablet 1 mg Tablet 2 mg 18.3.1.2 Insulin (Soluble) P,S,T Injection 40 IU/mL 18.3.1.3 Insulin Intermediate Acting (NPH)
P,S,T Injection 40 IU/mL

Medicine Level of 18.3.1.4 Insulin Glargine P,S,T Injection 100 IU/mL 18.3.1.5 Insulin Premix Injection 30:70
(Regular : NPH) P,S,T Injection 40 IU/mL 18.3.1.6 Metformin P,S,T Tablet 500 mg Tablet 1000 mg Modified release Tablet 1000 mg 18.3.1.7 Teneligliptin
P,S,T Tablet 20 mg 18.3.2 - Medicines used to treat Hypoglycemia

Medicine Level of 18.3.2.1 Glucose* P,S,T Injection 25 % 18.4-Ovulation Inducers

Medicine Level of 18.4.1 Clomiphene citrate T Tablet 50 mg Tablet 100 mg 18.4.2 Human chorionic gonadotropin S,T Injection 2000 IU Injection 5000 IU Injection 10000 IU *Glucose formulations are also listed in Section 25.1 - Solutions correcting water, electrolyte disturbances and acid-base disturbances

,T Injection 2000 IU Injection 5000 IU Injection 10000 IU *Glucose formulations are also listed in Section 25.1 - Solutions correcting water, electrolyte disturbances and acid-base disturbances

18.5-Progestogens

Medicine Level of 18.5.1 Medroxyprogesterone acetate P,S,T Tablet 5 mg Tablet 10 mg Injection 150 mg/ mL
18.5.2 Norethisterone P,S,T Tablet 5 mg 18.6-Thyroid and Antithyroid Medicines

Medicine Level of 18.6.1 Carbimazole P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg 18.6.2 Levothyroxine P,S,T Tablet 12.5 mcg to 150 mcg* (*Several strengths are available in market such as 12.5,25,50,62.5, 75, 88,100, 112mcg. Therefore, it was considered to give a range of available strengths) Section 19 Immunologicals In case of these biologicals, irrespective of variation in source, composition and strengths, all the products of the same vaccine/ sera/ immunoglobulin, as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, different products of the same biological should be considered differently for purposes such as procurement policy, pricing etc.

idering the source, process, technology and other relevant aspects, different products of the same biological should be considered differently for purposes such as procurement policy, pricing etc.

19.1-Diagnostic agents

Medicine Level of 19.1.1 Tuberculin, Purified Protein derivative P,S,T As Licensed 19.2-Sera and Immunoglobulins (Liquid/ Lyophilized)

Medicine Level of 19.2.1 Anti-rabies immunoglobulin P,S,T As Licensed 19.2.2 Anti-tetanus immunoglobulin P,S,T As Licensed 19.2.3 Anti-D immunoglobulin S,T As Licensed 19.2.4 Diphtheria antitoxin P,S,T As Licensed 19.2.5 Hepatitis B immunoglobulin S,T As Licensed 19.2.6 Human normal immunoglobulin T As Licensed 19.2.7

Snake Venom Antiserum*

P,S,T a) Soluble/ liquid polyvalent - As Licensed b) Lyophilized polyvalent - As Licensed *Snake Venom antiserum also listed in Section 4.2.12 - Antidotes and Other Substances used in Management of Poisonings/Envenomation Specific

As Licensed b) Lyophilized polyvalent - As Licensed *Snake Venom antiserum also listed in Section 4.2.12 - Antidotes and Other Substances used in Management of Poisonings/Envenomation Specific

19.3-Vaccines a) All the vaccines which are under Universal Immunization Program of India (UIP) will be deemed included in NLEM. Presently, the UIP has BCG, DPT, OPV, measles, Hepatitis B, Japanese encephalitis, Pentavalent Vaccines and Rota virus vaccine. b) The vaccines, which have been approved by National Technical Advisory Group on Immunization (NTAGI) and planned to be given under UIP, will be deemed to be included as and when listed in UIP. These vaccines are inactivated polio vaccine (IPV) and Measles Rubella (MR). c) In future, the vaccines which are under consideration, if and when included in UIP, will also be deemed included from the date of inclusion in UIP. These are pneumococcal and HPV vaccines. For Universal Immunization

Medicine Level of 19.3.1 BCG vaccine P,S,T As licensed 19.3.2 DPT+ Hib+ Hep B vaccine P,S,T As licensed 19.3.3 DPT vaccine P,S,T As licensed 19.3.4 Hepatitis B vaccine P,S,T As licensed 19.3.5 Japanese encephalitis vaccine P,S,T As licensed

19.3.2 DPT+ Hib+ Hep B vaccine P,S,T As licensed 19.3.3 DPT vaccine P,S,T As licensed 19.3.4 Hepatitis B vaccine P,S,T As licensed 19.3.5 Japanese encephalitis vaccine P,S,T As licensed

Medicine Level of 19.3.6 Measles vaccine P,S,T As licensed 19.3.7 Oral poliomyelitis vaccine P,S,T As licensed 19.3.8 Rotavirus vaccine P,S,T As licensed 19.3.9 Tetanus toxoid P,S,T As licensed 19.4 - For Specific Group of Individuals

Medicine Level of 19.4.1 Rabies vaccine P,S,T As licensed Section 20 Medicines for Neonatal Care

Medicine Level of 20.1 Alprostadil S,T Injection 0.5 mg/mL 20.2 Caffeine S,T Oral liquid 20 mg/mL
Injection 20 mg/mL 20.3 Surfactant S,T Suspension for intratracheal instillation (As licensed)

Section 21 Ophthalmological Medicines 21.1-Anti-infective Medicines

Medicine Level of 21.1.1 Acyclovir* P,S,T Ointment 3% 21.1.2 Ciprofloxacin** P,S,T Drops 0.3% Ointment 0.3% 21.1.3 Natamycin P,S,T Drops 5 % 21.1.4 Povidone iodine*** P,S,T Drops 5 % 21.2-Antiinflammatory Medicine

Medicine Level of 21.2.1 Prednisolone**** P,S,T Drops 1 % *Acyclovir formulations are also listed in -
A. Anti-infective Medicines -Antiviral medicines -Anti-herpes medicines Section 6.6.1.1 B. Anti-infective Medicines -Medicines used in the management of HIV -Medicines for treating Opportunistic Infections in People living with HIV Section 6.7.5.1 **Ciprofloxacin formulations are also listed in -
A. Section 6.2.2.3 - Anti-infective Medicines- Antibacterials - Other Antibacterials
B.

ic Infections in People living with HIV Section 6.7.5.1 **Ciprofloxacin formulations are also listed in -
A. Section 6.2.2.3 - Anti-infective Medicines- Antibacterials - Other Antibacterials
B. Section 16.2 Ear, Nose and Throat Medicines ***Povidone Iodine Also listed in Section 14.1.5 - Antiseptics and Disinfectants- Antiseptics

****Prednisolone formulations are also listed in - A. Section 3.7 - Antiallergics and Medicines used in Anaphylaxis
B. Section 7.2.4 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Hormones and anti-hormones used in cancer therapy
C. Section 18.1.5 - Hormones, other Endocrine Medicines and Contraceptives- Adrenal Hormones and synthetic substitutes

21.3- Local Anaesthetic

Medicine Level of 21.3.1 Proparacaine* P,S,T Drops 0.5 % 21.4-Miotics and Antiglaucoma Medicines

Medicine Level of 21.4.1 Acetazolamide P,S,T Tablet 250 mg 21.4.2 Latanoprost P,S,T Drops 0.005 % 21.4.3 Pilocarpine P,S,T Drops 2 % Drops 4 % 21.4.4 Timolol P,S,T Drops 0.25 % Drops 0.5 % 21.5-Mydriatics

Medicine Level of 21.5.1 Atropine** P,S,T Drops 1% Ointment 1% *Proparacaine formulations are also listed in listed in Section 12.1.2 -
Diagnostic agents- Ophthalmic Medicines
**Atropine formulations are also listed in -
A. Section 1.3.1 - Medicines used in Anaesthesia -Preoperative medication and sedation for short term procedures
B. Section 4.2.1 - Antidotes and Other substances used in Management of poisoning/Envenomation - specific

ines used in Anaesthesia -Preoperative medication and sedation for short term procedures
B. Section 4.2.1 - Antidotes and Other substances used in Management of poisoning/Envenomation - specific

Medicine Level of 21.5.2 Homatropine P,S,T Drops 2% 21.5.3 Phenylephrine P,S,T Drops 5 % Drops 10 % 21.5.4 Tropicamide* P,S,T Drops 1 % 21.6-Miscellaneous

Medicine Level of 21.6.1 Carboxymethyl cellulose P,S,T Drops 0.5% Drops 1% 21.6.2 Hydroxypropyl methylcellulose T Injection 2% Section 22 Oxytocics and Antioxytocics 22.1 - Oxytocics and Abortifacient

Medicine Level of 22.1.1 Dinoprostone S,T Tablet 0.5 mg Gel 0.5 mg 22.1.2 Methylergometrine P,S,T Tablet 0.125 mg Injection 0.2 mg/mL *Tropicamide formulations are also listed in Section 12.1.3 - Diagnostic agents - Ophthalmic Medicines

Medicine Level of 22.1.3 Mifepristone P,S,T Tablet 200 mg 22.1.4 Misoprostol P,S,T Tablet 100 mcg Tablet 200 mcg 22.1.5 Oxytocin P,S,T Injection 5 IU/mL Injection 10 IU/mL 22.2 - Medicines used in Preterm Labour

Medicine Level of 22.2.1 Betamethasone P,S,T Injection 4 mg/mL 22.2.2 Nifedipine S,T Tablet 10 mg Section 23 Medicines used in treatment of Psychiatric Disorders 23.1 - Medicines used in Psychotic Disorders

Medicine Level of 23.1.1 Clozapine T Tablet 25 mg Tablet 50 mg Tablet 100 mg 23.1.2 Fluphenazine P,S,T Injection 25 mg/mL

iatric Disorders 23.1 - Medicines used in Psychotic Disorders

Medicine Level of 23.1.1 Clozapine T Tablet 25 mg Tablet 50 mg Tablet 100 mg 23.1.2 Fluphenazine P,S,T Injection 25 mg/mL

Medicine Level of 23.1.3 Haloperidol* S,T Tablet 2 mg Tablet 5 mg Tablet 10 mg Tablet 20 mg Oral liquid 2 mg/5 mL Injection 5 mg/mL 23.1.4 Risperidone P,S,T Tablet 1 mg Tablet 2 mg Tablet 4 mg Oral liquid 1 mg/mL Injection (Long acting) 25 mg
Injection (Long acting) 37.5 mg
23.2 - Medicines used in Mood Disorders 23.2.1 - Medicines used in Depressive Disorders

Medicine Level of 23.2.1.1 Amitriptyline** P,S,T Tablet 10 mg Tablet 25 mg Tablet 50 mg Tablet 75 mg *Haloperidol formulations are also listed in Section 7.4.7 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care **Amitriptyline formulations are also listed in -
A. Section 5.2.5 - Medicines used in Neurological Disorders - Anti-migraine medicines-
For prophylaxis
B. Section 7.4.2 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care

Disorders - Anti-migraine medicines-
For prophylaxis
B. Section 7.4.2 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care

Medicine Level of 23.2.1.2 Escitalopram P,S,T Tablet 5 mg Tablet 10 mg Tablet 20 mg 23.2.1.3 Fluoxetine* P,S,T Capsule 10 mg Capsule 20 mg Capsule 40 mg Capsule 60 mg 23.2.2 - Medicines used in Bipolar Disorders

Medicine Level of 23.2.2.1 Lithium S,T Tablet 300 mg 23.2.2.2 Sodium valproate** P,S,T Tablet 200 mg Tablet 300 mg
Tablet 500 mg Modified Release - Tablet 300 mg Tablet 500 mg 23.2.2.3 Carbamazepine*** P,S,T Tablet 100 mg Tablet 200 mg Tablet 400 mg Modified Release - Tablet 200 mg
Tablet 400 mg Oral liquid 100 mg/5 mL (p) *Fluoxetine formulations are also listed in -
A. Section 7.4.6 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care B. Section 7.4.6 - Medicines used in treatment of psychiatric Disorders - Medicines used in obsessive compulsive disorders and panic attacks ** Sodium Valproate formulations are also listed in Section 5.1.10 - Medicines used in Neurological Disorders -Anticonvulsants /antiepileptics
***Carbamazepine formulations are also listed in Section 5.1.1 - Medicines used in Neurological Disorders- Anticonvulsants/antiepileptics

Neurological Disorders -Anticonvulsants /antiepileptics
***Carbamazepine formulations are also listed in Section 5.1.1 - Medicines used in Neurological Disorders- Anticonvulsants/antiepileptics

23.3 - Medicines used in Generalized Anxiety and Sleep Disorders

Medicine Level of 23.3.1 Clonazepam P,S,T Tablet 0.25 mg Tablet 0.5 mg Tablet 1 mg 23.3.2 Zolpidem P,S,T Tablet 5 mg Tablet 10 mg 23.4 - Medicines used in Obsessive Compulsive Disorders and Panic attacks

Medicine Level of 23.4.1 Clomipramine P,S,T Capsule 10 mg Capsule 25 mg Capsule 75 mg 23.4.2 Fluoxetine* S,T Capsule 10 mg Capsule 20 mg Capsule 40 mg Capsule 60 mg *Fluoxetine formulations are also listed in - A. Section 7.4.6 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care B. Section 23.2.1.3 Medicines used in treatment of Psychiatric Disorders - Medicines used in mood disorders - Medicines used in depressive disorders

liative are- Medicines used in Palliative Care B. Section 23.2.1.3 Medicines used in treatment of Psychiatric Disorders - Medicines used in mood disorders - Medicines used in depressive disorders

23.5 Medicines used in Disorders due to Psychoactive substance abuse

Medicine Level of 23.5.1 Buprenorphine P,S,T Tablet (Sub-lingual) 0.4 mg 23.5.2 Buprenorphine (A) + Naloxone (B) P,S,T Tablet (Sub-lingual) 0.4 mg (A)

0.1 mg (B) Tablet (Sub-lingual) 2 mg (A) + 0.5 mg (B) 23.5.3 Nicotine
(for nicotine replacement therapy) P,S,T Oral Dosage forms 2 mg Oral Dosage forms 4 mg Section 24 Medicines acting on the Respiratory tract 24.1 - Antiasthmatic Medicines

Medicine Level of 24.1.1 Budesonide* P,S,T Inhalation (MDI/DPI) 100 mcg/dose Inhalation (MDI/DPI) 200 mcg/dose Respirator solution for use in nebulizer 0.5 mg/mL
Respirator solution for use in nebulizer 1 mg/mL *Budesonide formulations are also listed in Section 16.1 - Ear, Nose and Throat Medicines

se Respirator solution for use in nebulizer 0.5 mg/mL
Respirator solution for use in nebulizer 1 mg/mL *Budesonide formulations are also listed in Section 16.1 - Ear, Nose and Throat Medicines

Medicine Level of 24.1.2 Budesonide (A) + Formoterol (B) P,S,T Inhalation (MDI/DPI) 100 mcg (A)

6 mcg (B) Inhalation (MDI/DPI) 200 mcg (A)
6 mcg (B) Inhalation (MDI/DPI) 400 mcg (A)
6 mcg (B) 24.1.3 Hydrocortisone* P,S,T Powder for Injection 100 mg Powder for Injection 200 mg 24.1.4 Ipratropium P,S,T Inhalation (MDI/DPI) 20 mcg/dose
Respirator solution for use
in nebulizer 250 mcg/mL 24.1.5 Montelukast S,T Tablet 4 mg
Tablet 5 mg
(including chewable tablets) Tablet 10 mg 24.1.6 Salbutamol P,S,T Tablet 2 mg Tablet 4 mg Oral liquid 2 mg/5 mL Inhalation (MDI/DPI*) 100 mcg/dose Respirator Solution
(Solution for Nebulizer 5 mg/mL) *Hydrocortisone formulations are also listed in - A. Section 3.5 - Antiallergics and Medicines used in Anaphylaxis
B. Section 18.1.3 - Hormones, other Endocrine Medicines and Contraceptives-
Adrenal hormones and synthetic substitutes

sted in - A. Section 3.5 - Antiallergics and Medicines used in Anaphylaxis
B. Section 18.1.3 - Hormones, other Endocrine Medicines and Contraceptives-
Adrenal hormones and synthetic substitutes

Medicine Level of 24.1.7 Tiotropium P,S,T Inhalation (MDI) 9 mcg/dose Inhalation (DPI) 18 mcg/dose MDI- Metered Dose Inhaler DPI- Dry Powder Inhaler Section 25 Solutions correcting Water, Electrolyte disturbances
and Acid-base disturbances

Medicine Level of 25.1.1 Glucose* P,S,T Injection 5 % Injection 10 % Injection 25 % Injection 50 % 25.1.2 Glucose(A) + Sodium chloride (B) P,S,T Injection 5% (A) + 0.9 % (B) 25.1.3 Oral rehydration salts** P,S,T As licensed 25.1.4 Potassium chloride P,S,T Oral liquid 500 mg/5 mL
S,T Injection 150 mg/mL *Glucose formulations are also listed in Section 18.4.2.1 - Hormones, other Endocrine Medicines and Contraceptives - Medicines used in diabetes mellitus - Medicines used to treat hypoglycemia

**Oral rehydration salts are also listed in Section 17.6.1 - Gastrointestinal Medicines - Medicines used in diarrhea

Medicines used in diabetes mellitus - Medicines used to treat hypoglycemia

**Oral rehydration salts are also listed in Section 17.6.1 - Gastrointestinal Medicines - Medicines used in diarrhea

Medicine Level of 25.1.5 Ringer lactate P,S,T Injection (as per IP) 25.1.6 Sodium bicarbonate P,S,T Injection (as per IP) 25.1.7 Sodium chloride P,S,T Injection 0.9% S,T Injection 3% 25.2-Miscellaneous

Medicine Level of 25.2.1 Water for Injection P,S,T Injection Section 26 Vitamins and Minerals

Medicine Level of 26.1 Ascorbic acid (Vitamin C) P,S,T Tablet 100 mg Tablet 500 mg 26.2 Calcium carbonate P,S,T Tablet 625 mg (equivalent to elemental calcium 250 mg) Tablet 1250 mg (equivalent to elemental calcium 500 mg) 26.3 Calcium gluconate* P,S,T Injection 100 mg/mL 26.4 Cholecalciferol P,S,T Solid oral dosage form 1000 IU Solid oral dosage form 60000 IU Oral liquid 400 IU/mL *Calcium Gluconate formulations are also listed in Section 4.2.2 - Antidotes and Other substances used in poisoning/Envenomation Specific

Solid oral dosage form 60000 IU Oral liquid 400 IU/mL *Calcium Gluconate formulations are also listed in Section 4.2.2 - Antidotes and Other substances used in poisoning/Envenomation Specific

Medicine Level of 26.5 Pyridoxine P,S,T Tablet 10 mg Tablet 50 mg Tablet 100 mg 26.6 Riboflavin P,S,T Tablet 10 mg 26.7 Thiamine P,S,T Tablet 100 mg Injection 100 mg/mL 26.8 Vitamin A P,S,T Capsule/Tablet 50000 IU (including Chewable Tablet) Oral liquid 100000 IU/mL Injection 50000 IU/mL Section 27 Medicines for COVID 19 management 27.1 Dexamethasone* P,S,T Tablet 0.5 mg Tablet 2 mg Tablet 4 mg Oral liquid 0.5 mg/5 mL (p) Injection 4 mg/mL 27.2 Enoxaparin** S,T Injection 40 mg/ 0.4 mL
Injection 60 mg/ 0.6 mL
*Dexamethasone is also listed in -
A. Section 3.4 - Antiallergics and Medicines used in Anaphylaxis
B. Section 7.4.3 - Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care C. Section 18.1.1 - Hormones, other Endocrine Medicines and Contraceptives - Adrenal hormones and synthetic substitutes

**Enoxaparin is also listed in -
A. Section 8.2.1 - Medicines affecting Blood - Medicines affecting coagulation
B. Section 10.5.4 - Cardiovascular medicines - Antiplatelet and Antithrombotic Medicines

aparin is also listed in -
A. Section 8.2.1 - Medicines affecting Blood - Medicines affecting coagulation
B. Section 10.5.4 - Cardiovascular medicines - Antiplatelet and Antithrombotic Medicines

Medicine Level of 27.3 Methylprednisolone * S,T Injection 40 mg/mL 27.4 Paracetamol** P,S,T Tablet 500 mg Tablet 650 mg Oral liquid 120 mg/5 mL (p) Oral Liquid 125 mg/5 mL (p) Oral Liquid 250 mg/5 mL (p) 27.5 Oxygen*** P,S,T As licensed for medical purpose

*Methylprednisolone is also listed in Section 18.1.4 - Hormones, other Endocrine medicines and Contraceptives- Adrenal Hormones and synthetic substitutes

**Paracetamol is also listed in
A. Section 2.1.5 - Analgesics, antipyretics, non steroidal anti-inflammatory medicines, medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders- Non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory medicines
B. Section 5.2.3 - Medicines used in Neurological Disorders-Antimigraine medicines

*** Oxygen is also listed in Medicines used in Section 1.1.5 - Anaesthesia- General Anaesthetics and Oxygen

All modified release formulations of same strength such as sustained release, controlled release, extended release, prolonged release etc. are included.

Alphabetical List
of Medicines in NLEM 2022

modified release formulations of same strength such as sustained release, controlled release, extended release, prolonged release etc. are included.

Alphabetical List
of Medicines in NLEM 2022

Alphabetical List of Medicines in NLEM 2022

5-aminosalicylic acid (Mesalazine/Mesalaine)
5-Fluorouracil
6-Mercaptopurine
Abacavir
Abacavir (A) + Lamivudine (B)
Acetazolamide
Acetylsalicylic acid
Actinomycin D
Activated Charcoal
Acyclovir
Adenosine
Adrenaline
Albendazole
Allopurinol
All-trans retinoic acid
Alprostadil
Amikacin
Amiodarone
Amitriptyline
Amlodipine
Amoxicillin
Amoxicillin (A) + Clavulanic acid (B)
Amphotericin B
a) Amphotericin B (conventional)
b) Lipid Amphotericin B
c) Liposomal Amphotericin B
Ampicillin
Anti-D immunoglobulin
Anti-rabies immunoglobulin
Anti-tetanus immunoglobulin
Arsenic trioxide
Artemether (A) + Lumefantrine (B)
Artesunate
Artesunate (A) + Sulphadoxine Pyrimethamine (B)
Ascorbic acid (Vitamin C)
Atazanavir (A) + Ritonavir (B)
Atorvastatin
Atracurium
Atropine
Azathioprine
Azithromycin
Baclofen
Barium sulphate
BCG vaccine
Bedaquiline
Bendamustine Hydrochloride
Benzathine benzylpenicillin
Benzoyl peroxide
Benzylpenicillin
Betamethasone
Betamethasone (valerate)
Bicalutamide

ccine 42. Bedaquiline 43. Bendamustine Hydrochloride 44. Benzathine benzylpenicillin 45. Benzoyl peroxide 46. Benzylpenicillin 47. Betamethasone 48. Betamethasone (valerate) 49. Bicalutamide

Bisacodyl
Bleomycin
Bortezomib
Budesonide
Budesonide (A) +Formoterol (B)
Bupivacaine
Buprenorphine
Buprenorphine (A) + Naloxone (B)
Caffeine
Calamine
Calcium carbonate
Calcium folinate
Calcium gluconate
Capecitabine
Carbamazepine
Carbimazole
Carboplatin
Carboxymethyl cellulose
Cefadroxil
Cefazolin
Cefixime
Cefotaxime
Ceftazidime
Ceftriaxone
Cefuroxime
Cetirizine
Chlorambucil
Chlorhexidine
Chloroquine
Cholecalciferol
Ciprofloxacin
Cisplatin
Clarithromycin
Clindamycin
Clobazam
Clofazimine
Clomiphene citrate
Clomipramine
Clonazepam
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Coagulation factor IX
Coagulation factor VIII
Coal tar (A) + Salicylic Acid (B)
Colchicine
Condom
Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)]
Cryoprecipitate
Cyclophosphamide

Coagulation factor VIII 95. Coal tar (A) + Salicylic Acid (B) 96. Colchicine 97. Condom 98. Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)] 99. Cryoprecipitate 100. Cyclophosphamide

Cycloserine
Cyclosporine
Cytosine arabinoside
D- Penicillamine
Dabigatran
Dacarbazine
Daclatasvir
Dapsone
Darunavir
Darunavir (A) + Ritonavir (B)
Daunorubicin
Delamanid
Desferrioxamine
Dexamethasone
Dextran-40
Diazepam
Diclofenac
Dicyclomine
Diethylcarbamazine
Digoxin
Diltiazem
Dinoprostone
Diphtheria antitoxin
Dobutamine
Docetaxel
Dolutegravir
Domperidone
Donepezil
Dopamine
Doxorubicin
Doxycycline
DPT vaccine
DPT+ Hib+ Hep B vaccine
Efavirenz
Enalapril
Enoxaparin
Entecavir
Erythropoietin
Escitalopram
Esmolol
Ethambutol
Ethinylestradiol (A) + Levonorgestrel (B)
Ethionamide
Ethyl alcohol (Denatured)
Etoposide
Fentanyl
Ferrous Salts (A) + Folic Acid (B)
Ferrous salts
Filgrastim
Fluconazole

Levonorgestrel (B)

Ethionamide
Ethyl alcohol (Denatured)
Etoposide
Fentanyl
Ferrous Salts (A) + Folic Acid (B)
Ferrous salts
Filgrastim
Fluconazole
Fludrocortisone
Flunarizine
Fluorescein
Fluoxetine
Fluphenazine
Folic Acid
Framycetin
Fresh frozen plasma
Furosemide
Fusidic acid
Gadobenate dimeglumine
Gefitinib
Gemcitabine
Gentamicin
Glimepiride
Glucose
Glucose(A) + Sodium chloride (B)
Glutaraldehyde
Glycerin
Glyceryl trinitrate
Glycopyrrolate
Griseofulvin
Haemodialysis fluid
Haloperidol
Halothane
Heparin
Hepatitis B immunoglobulin
Hepatitis B vaccine
Homatropine
Hormone releasing IUD
Human chorionic gonadotropin
Human normal immunoglobulin
Hydrochlorothiazide
Hydrocortisone
Hydrogen Peroxide
Hydroxocobalamine
Hydroxychloroquine
Hydroxypropyl methylcellulose
Hydroxyurea
Hyoscine butylbromide
Ibuprofen
Ifosfamide
Imatinib
Insulin (Soluble)
Insulin Glargine
Insulin Intermediate Acting (NPH)
Insulin Premix Injection 30:70 (Regular : NPH)
Iohexol
Ipratropium
Irinotecan HCI Trihydrate
Iron sucrose
Insulin Glargine
Insulin Intermediate Acting (NPH)
Insulin Premix Injection 30:70 (Regular : NPH)
Iohexol
Ipratropium
Irinotecan HCI Trihydrate
Iron sucrose
Isoflurane
Isoniazid
Isosorbide dinitrate
Ispaghula
Itraconazole
IUD containing Copper
Ivermectin
Japanese Encephalitis Vaccine
Ketamine
Labetalol
Lactulose
Lamivudine
L-Asparaginase
Latanoprost
Lenalidomide
Letrozole
Leuprolide acetate
Levetiracetam
Levodopa (A) + Carbidopa (B)
Levofloxacin
Levonorgestrel
Levothyroxine
Lignocaine
Lignocaine (A) + Adrenaline (B)
Linezolid
Lithium
Loperamide
Lopinavir (A) + Ritonavir (B)
Lorazepam
Magnesium sulphate
Mannitol
Measles vaccine
Mebendazole
Medroxyprogesterone acetate
Mefenamic acid
Mefloquine
Meglumine diatrizoate
Melphalan
Meropenem
Mesna
Metformin
Methotrexate
Methylergometrine
Methylprednisolone
Methylrosanilinium chloride (Gentian Violet)
Methylthioninium chloride (Methylene blue)
Metoclopramide
Metoprolol
Metronidazole
Midazolam
Mifepristone
Miltefosine

rosanilinium chloride (Gentian Violet) 247. Methylthioninium chloride (Methylene blue) 248. Metoclopramide 249. Metoprolol 250. Metronidazole 251. Midazolam 252. Mifepristone 253. Miltefosine

Misoprostol
Montelukast
Morphine
Moxifloxacin
Mupirocin
Mycophenolate mofetil
N-acetylcysteine
Naloxone
Natamycin
Neostigmine
Nevirapine
Nicotine replacement therapy (NRT)
Nifedipine
Nitrofurantoin
Nitrous oxide
Noradrenaline
Norethisterone
Nystatin
Omeprazole
Ondansetron
Oral poliomyelitis vaccine
Oral rehydration salts
Ormeloxifene (Centchroman)
Oxaliplatin
Oxygen
Oxytocin
Paclitaxel
Pantoprazole
Para- aminosalicylic acid
Paracetamol
Paromomycin
Peritoneal dialysis solution
Permethrin
Pheniramine
Phenobarbitone
Phenoxymethyl penicillin
Phenylephrine
Phenytoin
Phytomenadione(Vitamin K1)
Pilocarpine
Piperacillin (A) + Tazobactam (B)*
Platelet rich plasma/ Platelet concentrates
Podophyllin resin
Potassium chloride
Potassium permanganate
Povidone iodine
Pralidoxime chloride (2-PAM)
Praziquantel
Prednisolone
Primaquine
Procaine Benzylpenicillin
Potassium chloride
Potassium permanganate
Povidone iodine
Pralidoxime chloride (2-PAM)
Praziquantel
Prednisolone
Primaquine
Procaine Benzylpenicillin
Proparacaine
Propofol
Propranolol
Protamine Sulphate
Pyrazinamide
Pyridoxine
Quinine
Rabies vaccine
Raltegravir
Ramipril
Red blood cells/ Packed RBCs
Ribavirin
Riboflavin
Rifampicin
Ringer lactate
Risperidone
Ritonavir
Rituximab
Rotavirus vaccine
Salbutamol
Salicylic acid
Sevoflurane
Silver sulphadiazine
Snake Venom Antiserum
a. Soluble/ liquid polyvalent
b. Lyophilized polyvalent
Sodium bicarbonate
Sodium chloride
Sodium nitrite
Sodium nitroprusside
Sodium thiosulphate
Sodium Valproate
Sofosbuvir
Somatostatin
Spironolactone
Streptokinase
Streptomycin
Succinylcholine
Sulfasalazine
Sumatriptan
Surfactant
Tacrolimus
Tamoxifen
Telmisartan
Temozolomide
Tenecteplase
Teneligliptin
Tenofovir (A) + Lamivudine (B)
Sulfasalazine
Sumatriptan
Surfactant
Tacrolimus
Tamoxifen
Telmisartan
Temozolomide
Tenecteplase
Teneligliptin
Tenofovir (A) + Lamivudine (B)
Tenofovir (A) + Lamivudine (B) + Dolutegravir (C)
Tenofovir (A) + Lamivudine (B) + Efavirenz (C)
Tenofovir Alafenamide Fumarate (TAF)
Tenofovir Disproxil Fumarate (TDF)
Terbinafine
Tetanus toxoid
Thalidomide
Thiamine
Thiopentone
Timolol
Tiotropium
Tramadol
Tranexamic acid
Trastuzumab
Trihexyphenidyl
Tropicamide
Tuberculin, Purified Protein derivative
Valganciclovir
Vancomycin
Vecuronium
Verapamil
Vinblastine
Vincristine
Vitamin A
Warfarin
Water for Injection
Whole blood
Xylometazoline
Zidovudine
Zidovudine (A) + Lamivudine (B)
Zidovudine (A) + Lamivudine (B) + Nevirapine (C)
Zinc Sulphate
Zoledronic acid
Zolpidem

Medicines Added Therapeutic category wise in
NLEM 2022

Medicines Added Therapeutic category wise in NLEM 2022 Section 1 Medicines used in Anaesthesia NIL Section 2 Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders NIL Section 3 Antiallergics and medicines used in anaphylaxis NIL Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation NIL Section 5
Medicines used in Neurological disorders NIL

rgics and medicines used in anaphylaxis NIL Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation NIL Section 5
Medicines used in Neurological disorders NIL

Section 6 Anti-infective medicines 6.1.2 -Antifilarial

Medicine Level of
Healthcare 1 6.1.5 Ivermectin P,S,T Tablet 6 mg Tablet 12 mg 6.2-Antibacterials 6.2.1 Beta-lactam Medicines 2 6.2.1.14 Meropenem T Powder for Injection 500 mg (as trihydrate) (as trihydrate)
6.2.2 - Other antibacterials

Medicine Level of 3 6.2.2.2 Cefuroxime P,S,T Tablet 500 mg Syrup 125 mg/ 5 mL (p) Injection 1500 mg
4 6.2.2.11 Phenoxymethyl penicillin P,S,T Tablet 250 mg 5 6.2.2.12 Procaine Benzylpenicillin P,S,T Powder for injection
1000 mg (=1 million IU) 6.4-Antituberculosis medicines

Medicine Level of 6 6.4.1 Amikacin S,T Injection 100 mg/mL Injection 250 mg/mL Injection 500 mg/mL 7 6.4.2 Bedaquiline T Tablet 100 mg 8 6.4.7 Delamanid T Tablet 50 mg 6.5-Antifungal medicines

Medicine Level of 9 6.5.5 Itraconazole S,T Capsule 100 mg
Capsule 200 mg
Oral liquid 10 mg/mL
10 6.5.6 Mupirocin P,S,T Ointment 2% 11 6.5.8 Terbinafine P,S,T Cream 1%
6.6.2 - Anti-Cytomegalovirus (CMV) medicines

Medicine Level of 12 6.6.2.1 Valganciclovir S, T Tablet 450 mg Powder for oral solution 50 mg/mL

2% 11 6.5.8 Terbinafine P,S,T Cream 1%
6.6.2 - Anti-Cytomegalovirus (CMV) medicines

Medicine Level of 12 6.6.2.1 Valganciclovir S, T Tablet 450 mg Powder for oral solution 50 mg/mL

6.7- Medicines used in the Management of HIV
13 6.7.1.3 Lamivudine S,T Tablet 100 mg
Tablet 150 mg 14 6.7.1.5 Tenofovir (A) + Lamivudine (B) + Dolutegravir (C) P,S,T Tablet 300 mg (A) +
300 mg (B) + 50 mg (C)
6.7.3 - Integrase inhibitors

Medicine Level of 15 6.7.3.1 Dolutegravir S,T Tablet 50 mg
6.7.4-Protease inhibitors

Medicine Level of 16 6.7.4.3 Darunavir (A) + Ritonavir (B) S,T Tablet 600 mg (A) + Tablet 100 mg (B) 6.8 - Medicines for hepatitis B and hepatitis C

Medicine Level of 17 6.8.1 Daclatasvir S,T Tablet 60 mg Tablet 30 mg

18 6.8.5 Tenofovir Alafenamide Fumarate (TAF) S,T Tablet 25 mg Section 7 Antimigraine medicines (Now in Section 5 Medicines used in Neurological Disorders) NIL

Section 8
Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care (Now in Section 7) 7.1- Antineoplastic Medicines

Medicine Level of Healthcare 19 7.1.6 Bendamustine Hydrochloride T Injection 25 mg Injection 100 mg/vial
20 7.1.26 Irinotecan HCI Trihydrate T Solution for injection 20 mg/ mL 21 7.1.28 Lenalidomide T Capsule 5 mg Capsule 25 mg
7.2-Hormones and anti-hormones used in cancer therapy

g/vial
20 7.1.26 Irinotecan HCI Trihydrate T Solution for injection 20 mg/ mL 21 7.1.28 Lenalidomide T Capsule 5 mg Capsule 25 mg
7.2-Hormones and anti-hormones used in cancer therapy

Medicine Level of 22 7.2.3 Leuprolide acetate T Powder for injection 3.75 mg Powder for injection 11.25 mg Powder for injection 22.5 mg
Section 8 Medicines affecting Blood NIL Section 9 Antiparkinsonism medicines
(Now in Section 5.3 Medicines used in Neurological Disorders) NIL Section 10 Medicines affecting Blood NIL Section 11 Blood products and Plasma substitutes NIL Section 12 Cardiovascular Medicines (Now in Section 10)

10.5- Antiplatelet and Antithrombotic Medicines

Medicine Level of Healthcare 23 10.5.3 Dabigatran S, T Tablet 110 mg Tablet 150 mg 24 10.5.7 Tenecteplase S,T Injection 30 mg/vial Injection 40 mg/vial Section 13 Dermatological medicines (Topical) NIL Section 14 Dermatological medicines (Topical) NIL Section 15 Diagnostic Agents NIL Section 16 Dialysis solutions NIL

Section 17 Disinfectants and Antiseptics and NIL Section 18 Diuretics NIL Section 19 Ear, Nose and Throatmedicines NIL Section 20 Gastrointestinal medicines NIL Section 21 Hormones, other Endocrine Medicines and Contraceptives (Now in Section 18) 18.1-Adrenal Hormones and Synthetic substitutes

Medicine Level of 25 18.1.2 Fludrocortisone
S,T Tablet 100 mcg 18.2 - Contraceptives
18.2.1 - Hormonal Contraceptives

Medicine Level of 26 18.2.3 Ormeloxifene P,S,T Tablet 30 mg

Medicine Level of 25 18.1.2 Fludrocortisone
S,T Tablet 100 mcg 18.2 - Contraceptives
18.2.1 - Hormonal Contraceptives

Medicine Level of 26 18.2.3 Ormeloxifene P,S,T Tablet 30 mg

(Centchroman)

18.3 Medicines used in diabetes mellitus

18.3.1 Insulins and other antidiabetic agents 27 18.3.1.4 Insulin Glargine P,S,T Injection 100 IU/mL 28 18.3.1.7 Teneligliptin
P,S,T Tablet 20 mg Section 22 Immunologicals (Now in Section 19) For universal immunization

Medicine Level of 29 19.4.8 Rotavirus vaccine P, S, T As licensed Section 23 Muscle relaxants and cholinesterase inhibitors (Now in Section 1- Medicines used in Anaesthesia)
(sub-section 1.4 - Muscle relaxants and cholinesterase inhibitors) NIL

Section 24 Medicines for neonatal care NIL Section 25 Ophthalmological Medicines (Now in Section 21) 21.4-Miotics and Antiglaucoma Medicines

Medicine Level of Healthcare 30 21.4.2 Latanoprost P,S,T Drops 0.005 % Section 26 Oxytocics and Antioxytocic NIL Section 27 Medicines used in treatment of Psychiatric Disorders (Now in Section 23) 23.5-Medicines for disorders due to psychoactive substance abuse

Medicine Level of Healthcare

tocic NIL Section 27 Medicines used in treatment of Psychiatric Disorders (Now in Section 23) 23.5-Medicines for disorders due to psychoactive substance abuse

Medicine Level of Healthcare

31 23.5.1 Buprenorphine P,S,T Tablet (Sub-lingual) 0.4 mg 32 23.5.2 Buprenorphine (A) + Naloxone (B) P,S,T Tablet (Sub-lingual) 0.4 mg (A) + 0.1 mg (B) Tablet (Sub-lingual) 2 mg (A) + 0.5 mg (B) 33 23.5.3 Nicotine
(for nicotine replacement therapy) P,S,T Oral Dosage forms 2 mg Oral Dosage forms 4 mg Section 28 Medicines acting on the respiratory tract (Now in Section 24) 24.1-Antiasthmatic Medicines

Medicine Level of Healthcare 34 24.1.8 Montelukast S,T Tablet 4 mg
Tablet 5 mg
(including chewable tablets) Tablet 10 mg Section 29 Solutions correcting Water, Electrolyte disturbances
and Acid-base disturbances (Now in Section 25) NIL Section 30 Vitamins and minerals (Now in Section 26) NIL

Alphabetical List of Medicines Added to NLEM 2022

Amikacin
Bedaquiline
Bendamustine Hydrochloride
Buprenorphine
Buprenorphine (A) + Naloxone (B)
Cefuroxime
Dabigatran
Daclatasvir
Darunavir (A) + Ritonavir (B)
Delamanid
Dolutegravir
Fludrocortisone
Insulin Glargine
Irinotecan HCI Trihydrate
Itraconazole
Ivermectin
Lamivudine
Latanoprost

vir (A) + Ritonavir (B) 10. Delamanid 11. Dolutegravir 12. Fludrocortisone
13. Insulin Glargine 14. Irinotecan HCI Trihydrate 15. Itraconazole 16. Ivermectin 17. Lamivudine 18. Latanoprost

Alphabetical List of Medicines Added to NLEM 2022

Lenalidomide
Leuprolide acetate
Meropenem
Montelukast
Mupirocin
Nicotine replacement therapy (NRT)
Ormeloxifene (Centchroman)
Phenoxymethyl penicillin
Procaine Benzyl penicillin
Rotavirus vaccine
Tenecteplase
Teneligliptin
Tenofovir (A) + Lamivudine (B) + Dolutegravir (C)
Tenofovir Alafenamide Fumarate (TAF)
Terbinafine
Valganciclovir

Medicines Deleted from Therapeutic category wise
NLEM 2015

Medicines Deleted from Therapeutic category wise NLEM 2015 Section 1 Anaesthetic Agents

Medicine Level of Healthcare 1 1.2.4
Prilocaine (A) + Lignocaine (B) T Cream 2.5% (A) + 2.5% (B) Section 2-Analgesics, antipyretics, non-steroidal anti-inflammatory medicines, medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders

Medicine Level of Healthcare 2 2.4.3
Leflunomide S,T Tablet 10 mg Tablet 20 mg Section 3-Antiallergics and medicines used in anaphylaxis

Medicine Level of 3 3.3 Chlorpheniramine P,S,T Tablet 4 mg Oral liquid 2 mg/5 ml Section 4-Antidotes and Other substances used in poisoning treatment

4.2 Specific

Medicine Level of

Medicine Level of 3 3.3 Chlorpheniramine P,S,T Tablet 4 mg Oral liquid 2 mg/5 ml Section 4-Antidotes and Other substances used in poisoning treatment

4.2 Specific

Medicine Level of

Healthcare 4 4.2.4 Dimercaprol S,T

Injection 50 mg/ml Section 5 Medicines used in Neurological Disorders NIL Section 6-Anti-infective medicines 6.2.4-Antituberculosis medicines

Medicine Level of 5 6.2.4.1 Capreomycin P,S,T Powder for Injection 1 g 6 6.2.4.6 Kanamycin P,S,T Powder for Injection 750 mg Powder for Injection 1 g 7 6.2.4.12
Rifabutin S,T Capsule 150 mg 6.4.2-Anti Cytomegalovirus (CMV) medicines

Medicine Level of Healthcare 8 6.4.2.1
Ganciclovir S,T Capsule 250 mg Powder for Injection 500 mg

6.4.3-Medicines used in the management of HIV 6.4.3.1 -Nucleoside reverse transcriptase inhibitors

Medicine Level of 9 6.4.3.1.3 Lamivudine (A) + Nevirapine (B) + Stavudine (B)
S,T Dispersible Tablet 30mg
(A) + 50mg (B) + 6mg (C) Tablet 150mg (A) + 200mg (B) + 30mg (C)

10 6.4.3.1.5 Stavudine (A) + Lamivudine (B)
S,T Dispersible Tablet 6 mg (A)

30 mg (B) (p) Tablet 30 mg (A) + 150 mg (B)
6.4.4-Medicines for hepatitis B and hepatitis C

Medicine Level of 11 6.4.4.2 Pegylated interferon alfa 2a S,T Injection 180 mcg Pegylated interferon alfa 2b S,T Injection 80 mcg Injection 100 mcg Injection 120 mcg

6.5.1 Antiamoebic and antigiardiasis medicines

.2 Pegylated interferon alfa 2a S,T Injection 180 mcg Pegylated interferon alfa 2b S,T Injection 80 mcg Injection 100 mcg Injection 120 mcg

6.5.1 Antiamoebic and antigiardiasis medicines

Medicine Level of 12 6.5.1.1 Diloxanide furoate P,S,T

Tablet 500 mg 6.5.4-Antipneumocystosis and antitoxoplasmosis medicines
13 6.5.4.2
Pentamidine S,T Powder for Injection 200 mg Section 7 Antimigraine medicines NIL Section 8 Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care NIL

Medicine Level of Healthcare 14

8.1.30 Procarbazine T Capsule 50 mg Section 9 Antiparkinsonism medicines NIL Section 10 Medicines affecting blood

NIL 10.3-Antihypertensive Medicines

Medicine Level of Healthcare 15 12.3.6 Methyldopa P,S,T Tablet 250 mg Tablet 500 mg Section 11 Blood products and Plasma substitutes NIL Section 12- Cardiovascular Medicines 12.3-Antihypertensive medicines

Medicine Level of Healthcare 16 12.3.2
Atenolol P,S,T Tablet 50 mg Tablet 100 mg 12.5-Antithrombotic medicine (Cardiovascular/ Cerebrovascular)

Medicine Level of Healthcare 17

12.5.2

Alteplase T Powder for Injection 20 mg
Powder for Injection 50 mg

ablet 100 mg 12.5-Antithrombotic medicine (Cardiovascular/ Cerebrovascular)

Medicine Level of Healthcare 17

12.5.2

Alteplase T Powder for Injection 20 mg
Powder for Injection 50 mg

Section 13 Dermatological medicines (Topical) NIL Section 14 Dermatological medicines (Topical) 14.6 Miscellaneous

Medicine Level of Healthcare 18 14.6.2
White Petrolatum P,S,T Jelly 100% Section 15 Diagnostic agents NIL Section 16 Dialysis solutions NIL Section 17 Antiseptics and Disinfectants 17.1- Antiseptics

Medicine Level of

19 17.1.1
Cetrimide P,S,T Solution 20 %
(Concentrate for dilution) 17.2 Disinfectants
20 17.2.1
Bleaching powder
P,S,T Containing not less than 30%w/w of available chlorine (as per I.P) Section 18 Diuretics NIL Section 19 Ear, Nose and Throatmedicines NIL Section 20 Gastrointestinal medicines 20.1 Antiulcer medicines

Medicine Level of Healthcare

21 20.1.4
Sucralfate S,T Oral liquid 1g 22 20.1.3 Ranitidine P,S,T Tablet 150 mg Oral liquid 75 mg/5 mL Injection 25 mg/mL Section 21 Hormones, other Endocrine Medicines and Contraceptives 21.2.1 Hormonal contraceptives

Medicine Level of 23 21.2.1.2
Ethinylestradiol (A) + Norethisterone (B) P,S,T Tablet 0.035 mg (A) +1 mg (B) 21.3 Estrogens 24 21.3.1 Ethinylestradiol P,S,T

Tablet 0.01 mg Tablet 0.05 mg Section 22 Immunologicals NIL

Ethinylestradiol (A) + Norethisterone (B) P,S,T Tablet 0.035 mg (A) +1 mg (B) 21.3 Estrogens 24 21.3.1 Ethinylestradiol P,S,T

Tablet 0.01 mg Tablet 0.05 mg Section 22 Immunologicals NIL

Section 23 Muscle relaxants and cholinesterase inhibitors NIL Section 24 Medicines for neonatal care NIL Section 25 Ophthalmological Medicines 25.1-Anti-infective medicines

Medicine Level of 25 25.1.3 Erythromycin P,S,T Ointment 0.5 % Section 26 Oxytocics and Antioxytocics NIL Section 27 Medicines in treatment of Psychiatric Disorders

NIL Section 28 Medicines acting on the respiratory tract NIL Section 29 Solutions correcting water, electrolyte disturbances and acid-base disturbances NIL Section 30 Vitamins and minerals

Medicine Level of 26 30.5
Nicotinamide P,S,T Tablet 50 mg

Alphabetical List of Medicines Deleted from NLEM 2015

Alteplase
Atenolol
Bleaching Powder
Capreomycin
Cetrimide
Chlorpheniramine
Diloxanide furoate
Dimercaprol
Erythromycin
Ethinylestradiol
Ethinylestradiol(A) Norethisterone (B)
Ganciclovir
Kanamycin
Lamivudine (A) + Nevirapine (B) + Stavudine (C)
Leflunomide
Methyldopa
Nicotinamide
Pegylated interferon alfa 2a, Pegylated interferon alfa 2b
Pentamidine
Prilocaine (A) + Lignocaine (B)
Procarbazine
Ranitidine
Rifabutin
Stavudine (A) + Lamivudine (B)
Sucralfate
White Petrolatum

ed interferon alfa 2b 19. Pentamidine 20. Prilocaine (A) + Lignocaine (B) 21. Procarbazine

Ranitidine
Rifabutin
Stavudine (A) + Lamivudine (B)
Sucralfate
White Petrolatum

5-aminosalicylic acid, 61 5-Fluorouracil, 37 6-Mercaptopurine, 37 Abacavir, 28 Abacavir (A) + Lamivudine (B), 29 Acetazolamide, 72 Acetylsalicylic acid, 6, 15, 52 Actinomycin D, 37 Activated Charcoal, 11 Acyclovir, 28, 31, 71 Adenosine, 50 Adrenaline, 9 Albendazole, 18 Allopurinol, 8, 42 All-trans retinoic acid, 37 Alprostadil, 70 Amikacin, 24 Amiodarone, 50 Amitriptyline, 16, 42, 75 Amlodipine, 50 Amoxicillin, 19 Amoxicillin (A) + Clavulanic acid (B), 19 Amphotericin B, 26, 34 Ampicillin, 20 Anti-D immunoglobulin, 68 Anti-rabies immunoglobulin, 68 Anti-tetanus immunoglobulin, 68 Arsenic trioxide, 37 Artemether (A) + Lumefantrine (B), 35 Artesunate, 35 Artesunate (A) + Sulphadoxine - Pyrimethamine (B), 35 Ascorbic acid, 81 Atazanavir (A) + Ritonavir (B), 30 Atorvastatin, 53 Atracurium, 5 Atropine, 4, 11, 72 Azathioprine, 9, 41 Azithromycin, 21, 32 Baclofen, 5 Barium sulphate, 56 BCG vaccine, 69 Bedaquiline, 24 Bendamustine Hydrochloride, 37 Benzathine benzylpenicillin, 20 Benzoyl peroxide, 55 Benzylpenicillin, 20 Betamethasone, 74 Betamethasone (valerate), 54 Bicalutamide, 40 Bisacodyl, 61 Bleomycin, 37 Bortezomib, 37 Budesonide, 59, 78 Budesonide (A) +Formoterol (B), 79 Bupivacaine, 4 Buprenorphine, 78 Buprenorphine (A) + Naloxone (B), 78 Caffeine, 70 Calamine, 55 Calcium carbonate, 81 Calcium folinate, 37

desonide, 59, 78 Budesonide (A) +Formoterol (B), 79 Bupivacaine, 4 Buprenorphine, 78 Buprenorphine (A) + Naloxone (B), 78 Caffeine, 70 Calamine, 55 Calcium carbonate, 81 Calcium folinate, 37 Calcium gluconate, 11, 81 Capecitabine, 37 Carbamazepine, 13, 76 Carbimazole, 67 Carboplatin, 41 Carboxymethyl cellulose, 73 Cefadroxil, 20 Cefazolin, 20 Cefixime, 20 Cefotaxime, 20, 31 Ceftazidime, 21 Ceftriaxone, 21 Cefuroxime, 21 Cetirizine, 9 Chlorambucil, 38 Chlorhexidine, 57 Chloroquine, 36 Cholecalciferol, 81 Ciprofloxacin, 22, 59, 71 Cisplatin, 38 Clarithromycin, 22, 24 Clindamycin, 22, 31, 34, 36 Clobazam, 13 Clofazimine, 24, 25 Clomiphene citrate, 66 Clomipramine, 77 Clonazepam, 77 Clopidogrel, 53 INDEX

Clotrimazole, 27, 32, 54, 59 Cloxacillin, 21 Clozapine, 74 Coagulation factor IX, 48 Coagulation factor VIII, 48 Coal tar (A) + Salicylic Acid (B), 55 Colchicine, 8 Condom, 65 Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)], 22, 35 Cryoprecipitate, 48 Cyclophosphamide, 38 Cycloserine, 25 Cyclosporine, 41 Cytosine Arabinoside, 38 D- Penicillamine, 11 Dabigatran, 53 Dacarbazine, 38 Daclatasvir, 32 Dapsone, 24 Darunavir, 31 Darunavir (A) + Ritonavir (B), 31 Daunorubicin, 38 Delamanid, 25 Desferrioxamine, 11 Dexamethasone, 10, 42, 63, 82 Dextran-40, 48 Diazepam, 13, 43 Diclofenac, 7 Dicyclomine, 61 Diethylcarbamazine (DEC), 11 Digoxin, 50, 51 Diltiazem, 49 Dinoprostone, 73 Diphtheria antitoxin, 68 Dobutamine, 52 Docetaxel, 38 Dolutegravir, 30 Domperidone, 60 Donepezil, 17 Dopamine, 52

iethylcarbamazine (DEC), 11 Digoxin, 50, 51 Diltiazem, 49 Dinoprostone, 73 Diphtheria antitoxin, 68 Dobutamine, 52 Docetaxel, 38 Dolutegravir, 30 Domperidone, 60 Donepezil, 17 Dopamine, 52 Doxorubicin, 38 Doxycycline, 23, 36 DPT vaccine, 69 DPT+ Hib+ Hep B vaccine, 69 Efavirenz, 30 Enalapril, 51 Enoxaparin, 46, 53, 82 Entecavir, 32 Erythropoietin, 45 Escitalopram, 76 Esmolol, 50 Ethambutol, 25 Ethinylestradiol (A)+ Levonorgestrel (B), 64 Ethionamide, 25 Ethyl alcohol (Denatured), 57 Etoposide, 38 Fentanyl, 7 Ferrous Salt (A)+ Folic acid (B), 45 Ferrous salts, 45 Filgrastim, 43 Fluconazole, 27 Fludrocortisone, 63 Flunarizine, 17 Fluorescein, 56 Fluoxetine, 43, 76, 77 Fluphenazine, 74 Folic Acid, 46 Framycetin, 54 Fresh Frozen Plasma, 47 Furosemide, 58 Fusidic acid, 54 Gadobenate dimeglumine, 56 Gefitinib, 38 Gemcitabine, 39 Gentamicin, 23 Glimepiride, 65 Glucose(A) + Sodium chloride (B), 80 Glucose, 66, 80 Glutaraldehyde, 58 Glycerin (as mentioned in IP), 55 Glyceryl trinitrate, 49 Glycopyrrolate, 5 Griseofulvin, 27 Haemodialysis fluid, 57 Haloperidol, 75 Halothane, 3 Heparin, 46, 53 Hepatitis B immunoglobulin, 68 Hepatitis B vaccine, 69

P), 55 Glyceryl trinitrate, 49 Glycopyrrolate, 5 Griseofulvin, 27 Haemodialysis fluid, 57 Haloperidol, 75 Halothane, 3 Heparin, 46, 53 Hepatitis B immunoglobulin, 68 Hepatitis B vaccine, 69

Homatropine, 73 Hormone Releasing IUD, 65 Human chorionic gonadotropin, 66 Human normal immunoglobulin, 58 Hydrochlorothiazide, 51, 58 Hydrocortisone, 10, 63, 79 Hydrogen peroxide, 57 Hydroxocobalamin, 46 Hydroxychloroquine, 9 Hydroxypropyl methylcellulose, 73 Hydroxyurea, 39, 46 Hyoscine butyl bromide, 61 Ibuprofen, 7, 16 Ifosfamide, 39 Imatinib, 39 Insulin (Soluble), 65 Insulin Glargine, 66 Insulin Intermediate Acting (NPH), 65 Insulin Premix, 66 Iohexol, 56 Ipratropium, 79 Irinotecan HCI Trihydrate, 39 Iron sucrose, 46 Isoflurane, 3 Isoniazid, 25 Isosorbide dinitrate, 49 Isosorbide-5- mononitrate, 53 Ispaghula, 61 Itraconazole, 27 IUD containing Copper, 65 Ivermectin, 19 Japanese Encephalitis vaccine, 69 Ketamine, 3 Labetalol, 51 Lactulose, 43, 62 Lamivudine, 29 L-Asparaginase, 39 Latanoprost, 72 Lenalidomide, 39 Letrozole, 40 Leuprolide acetate, 41 Levetiracetam, 13 Levodopa (A) + Carbidopa (B), 17 Levofloxacin, 25 Levonorgestrel, 64 Levothyroxine, 67 Lignocaine, 4, 50 Lignocaine (A) + Adrenaline (B), 4 Linezolid, 25 Lithium, 76 Loperamide, 43 Lopinavir (A) + Ritonavir (B), 31 Lorazepam, 13 Magnesium sulphate, 14 Mannitol, 58 Measles vaccine, 70 Mebendazole, 18 Medroxyprogesterone acetate, 67 Mefenamic acid, 7 Mefloquine, 36 Meglumine diatrizoate, 56 Melphalan, 39 Meropenem, Mesna, 44 Metformin, 66

Mannitol, 58 Measles vaccine, 70 Mebendazole, 18 Medroxyprogesterone acetate, 67 Mefenamic acid, 7 Mefloquine, 36 Meglumine diatrizoate, 56 Melphalan, 39 Meropenem, Mesna, 44 Metformin, 66 Methotrexate, 9, 39 Methylergometrine, 73 Methylprednisolone, 63, 83 Methylrosanilinium chloride, 57 Methylthioninium chloride, 11 Metoclopramide, 44, 60 Metoprolol, 49 Metronidazole, 25, 33 Midazolam, 5, 14, 44 Mifepristone, 74 Miltefosine, 34 Misoprostol, 74 Montelukast, 79 Morphine, 5, 8, 44 Moxifloxacin, 25 Mupirocin, 27 Mycophenolate mofetil, 42 N-acetylcysteine, 12 Naloxone, 12 Natamycin, 71 Neostigmine, 6, 12 Nevirapine, 30 Nicotine (for nicotine replacement therapy), 78 Nifedipine, 74 Nitrofurantoin, 23

Nitrous oxide, 3 Noradrenaline, 52 Norethisterone, 67 Nystatin, 27 Omeprazole, 60 Ondansetron, 44, 60 Oral poliomyelitis vaccine, 70 Oral rehydration salts, 62, 80 Ormeloxifene, 64 Oxaliplatin, 40 Oxygen, 3, 83 Oxytocin, 74 Paclitaxel, 40 Pantoprazole, 60 Para- aminosalicylic acid, 26 Paracetamol, 7, 16, 83 Paromomycin, 34 Peritoneal dialysis solution, 57 Permethrin, 55 Pheniramine, 10 Phenobarbitone, 14 Phenoxymethyl penicillin, 23 Phenylephrine, 73 Phenytoin, 14 Phytomenadione, 46 Pilocarpine, 72 Piperacillin (A) + Tazobactam (B), 21 Platelet rich plasma/ Platelet concentrates, 47 Podophyllin resin, 55 Potassium chloride, 80 Potassium permanganate, 58 Povidone iodine, 57, 71 Pralidoxime chloride (2-PAM), 12 Praziquantel, 19 Prednisolone, 10, 41, 64, 71 Primaquine, 36 Procaine Benzylpenicillin, 23

ium chloride, 80 Potassium permanganate, 58 Povidone iodine, 57, 71 Pralidoxime chloride (2-PAM), 12 Praziquantel, 19 Prednisolone, 10, 41, 64, 71 Primaquine, 36 Procaine Benzylpenicillin, 23 Proparacaine, 56, 72 Propofol, 3 Propranolol, 17 Protamine Sulphate, 46 Pyrazinamide, 26 Pyridoxine, 82 Quinine, 36 Rabies vaccine, 70 Raltegravir, 30 Ramipril, 51 Red blood cells, 47 Ribavirin, 33 Riboflavin, 82 Rifampicin, 24, 26 Ringer lactate, 81 Risperidone, 75 Ritonavir, 31 Rituximab, 40 Rotavirus vaccine, 70 Salbutamol, 79 Salicylic acid, 55 Sevoflurane, 3 Silver sulphadiazine Snake Venom Antiserum, 12, 68 Sodium bicarbonate, 81 Sodium chloride, 81 Sodium nitrite, 12 Sodium Nitroprusside, 51 Sodium thiosulphate, 12 Sodium Valproate, 15, 76 Sofosbuvir, 33 Somatostatin, 62 Spironolactone, 52, 58 Streptokinase, 53 Streptomycin, 26 Succinylcholine, 6 Sulfasalazine, 9 Sumatriptan, 16 Surfactant, 70 Tacrolimus, 42 Tamoxifen, 41 Telmisartan, 51 Temozolomide, 40 Tenecteplase, 53 Teneligliptin, 66 Tenofovir Disoproxil fumarate (A) + Lamivudine (B), 29 Tenofovir Disoproxil fumarate (A) + Lamivudine (B) + Dolutegravir (C), 29 Tenofovir Disoproxil fumarate (A) + Lamivudine (B) + Efavirenz (C), 29 Tenofovir Alafenamide Fumarate (TAF), 33 Tenofovir Disproxil Fumarate (TDF), 29, 33

Lamivudine (B) + Dolutegravir (C), 29 Tenofovir Disoproxil fumarate (A) + Lamivudine (B) + Efavirenz (C), 29 Tenofovir Alafenamide Fumarate (TAF), 33 Tenofovir Disproxil Fumarate (TDF), 29, 33

Terbinafine, 27 Tetanus toxoid, 70 Thalidomide, 40 Thiamine, 82 Thiopentone, 3 Timolol, 72 Tiotropium, 80 Tramadol, 8, 45 Tranexamic acid, 46 Trastuzumab, 40 Trihexyphenidyl, 17 Tropicamide, 56, 73 Tuberculin Purified Protein derivative, 68 Valganciclovir, 28, 32 Vancomycin, 23 Vecuronium, 6 Verapamil, 50 Vinblastine, 40 Vincristine, 40 Vitamin A, 82 Warfarin, 47 Water for Injection, 81 Whole blood, 47 Xylometazoline, 59 Zidovudine, 29 Zidovudine (A) + Lamivudine (B), 29 Zidovudine (A) + Lamivudine (B) + Nevirapine (C),30
Zinc Sulphate, 62 Zoledronic acid, 45 Zolpidem, 77

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis has been generated for this document yet.